PRINTER:
PLEASE BUILD
IN SPINE
inTEST Corporation Corporate Headquarters
804 East Gate Drive, Suite 200
Mt. Laurel, NJ 08054 USA
Tel (856) 505-8800 Fax (856) 505-8801
www.intest.com
WE’RE NOT JUST SEMI…
WE’RE NOT JUST SEMI…
WE MAKE THINGS HOT & COLD WHERE IT MATTERS
WE MAKE THINGS HOT & COLD WHERE IT MATTERS
i
n
T
E
S
T
C
o
r
p
o
r
a
t
i
o
n
I
2
0
1
7
A
n
n
u
a
l
R
e
p
o
r
t
InTEST_2017AR_CV.indd 1
InTEST_2017AR_CV.indd 5
4/30/18 1:24 PM
4/30/18 1:24 PM
InTEST_2017AR_CV.indd 2
4/30/18 1:24 PM
001CSN346A
2017 Annual Report
Company Profile
Corporate
Information
inTEST Corporation (NYSE American:INTT) designs and manufactures engineered solutions for
Automated Test Equipment (ATE) and other electronic test, as well as industrial process applications. Our products
are used by semiconductor manufacturers to perform development, qualifying and final testing of integrated circuits
(ICs) and wafers, and for other electronic test across a range of industries including the automotive, defense/
aerospace, energy, industrial and telecommunications markets. We offer induction heating products for joining
and forming metals in a variety of industrial markets, including automotive, aerospace, machinery, wire & fasteners,
medical, semiconductor, food & beverage, and packaging. Specific products include temperature management
systems, induction heating products, manipulator and docking hardware products, and customized interface
solutions. We have established strong relationships with our customers globally, which we support through a
network of local offices.
Our largest customers include Analog Devices, Inc., Cypress Semiconductor Corporation, Foxconn Optical
Interconnect Technologies, Inc., Hakuto Co. Ltd., NaigaiTEC Corporation, NXP Semiconductors N.V.,
Rosendahl Nextrom GmbH, STMicroelectonics N.V., Teradyne, Inc., and Texas Instruments Incorporated.
We are headquartered in Mt. Laurel, NJ, with manufacturing facilities in NJ, MA, NY and CA. We also have
sales, service and support offices in Singapore, Germany, Netherlands and the U.K., with additional support
personnel in other key industrial manufacturing areas around the world.
BUSINESS SEGMENTS
Thermal Segment
Ambrell
EMS Products Segment
inTEST comprises two
business segments under
five brands – Ambrell,
Temptronic, Sigma
Systems, Thermonics,
and EMS Products –
that collectively focus
on electronic test,
process cooling, and
induction heating.
inTEST Thermal Solutions
(iTS): Thermal systems that
deliver precise temperature
from ultralow to high heat
for thermal conditioning in
electronic and production
test processes, as well as
adding or removing heat to
maintain a thermally stable
manufacturing or test site.
Induction heating
systems that deliver
precise temperature
used in production
processes for conditioning
metals such as annealing,
bonding, brazing, curing,
forging, hardening,
melting, sealing, shrink
fitting, and soldering.
inTEST EMS Products:
Manipulators, docking
systems and custom
electrical interfaces
critical to ATE systems
in the production of
semiconductors.
inTEST-semicon.com
inTESTthermal.com and
Thermonics-chillers.com
Ambrell.com
m
o
c
.
n
g
i
s
e
d
e
r
u
t
a
n
g
i
s
y
e
l
l
e
h
s
.
w
w
w
/
n
g
i
s
e
D
e
r
u
t
a
n
g
S
y
e
i
l
l
e
h
S
:
y
B
n
g
i
s
e
D
t
r
o
p
e
R
l
a
u
n
n
A
Executive Officers
James Pelrin
President and
Chief Executive Officer
Hugh T. Regan, Jr.
Secretary, Treasurer and
Chief Financial Officer
Is Transfer
Agent Copy
OK?
Board of Directors
Robert E. Matthiessen
Chairman, inTEST Corporation
James Pelrin
President and CEO,
inTEST Corporation
Steven J. Abrams, Esq.
Partner, Hogan Lovells US LLP
Joseph W. Dews IV
Partner, AGC Partners
William Kraut
Partner, Newport Board Group LLC
Legal Counsel
Ballard Spahr LLP
1735 Market Street – 51st Floor
Philadelphia, PA 19103-7599
Independent Registered
Public Accounting Firm
RSM US LLP
751 Arbor Way, Suite 200
Blue Bell, PA 19422-2700
Transfer Agent
Computershare Trust Company, N.A.
Attention: Shareholder Services
P.O. Box 505000
Louisville, KY 40233
800-962-4284
Investor Relations
Laura Guerrant-Oiye, Principal
Guerrant Associates
lguerrant@guerrantir.com
808-960-2642
Annual Stockholders’ Meeting
Our 2018 Annual Meeting
of Stockholders will be held
at 11:00 A.M. Eastern
Daylight Time on Wednesday,
June 27, 2018, at our offices,
804 East Gate Drive, Suite 200,
Mt. Laurel, New Jersey 08054.
Availability of Annual Report
on Form 10-K
A copy of our Annual Report
on Form 10-K for the year ended
December 31, 2017 (excluding
exhibits) as filed with the Securities
and Exchange Commission is
available to any stockholder
without charge, upon written
request to Hugh T. Regan, Jr.,
Secretary, inTEST Corporation,
804 East Gate Drive, Suite 200,
Mt. Laurel, NJ 08054, or by
calling (856) 505-8800. Copies
of the exhibits filed therewith will
be provided upon written request
to the Secretary of the Corporation
and payment of a reasonable
fee (which will not exceed our
expense incurred in connection with
providing such copies). In addition,
our Annual Report on Form 10-K
and all exhibits are available at no
charge by accessing the Investor
Relations page of our website, at
http://investor.shareholder.com/
intest/index.cfm, or the SEC’s
website, at www.sec.gov.
InTEST_2017AR_CV.indd 3
4/30/18 1:24 PM
InTEST_2017AR_CV.indd 4
4/30/18 1:24 PM
inTEST I 2017 Annual Report I Page 1
INVESTMENT HIGHLIGHTS
• Leading provider of mission-critical, yield improvement test solutions for growth industries
• Estimated addressable market in excess of $620 million annually
• Blue chip customers across auto, industrial, defense/aerospace, telecom and semi markets
• Successfully expanding addressable markets, product offerings and customer base via M&A
• Consistent growth and profitability, high margins, strong cash flows
• New CEO leading strong, proven team
GROWTH OPPORTUNITIES
• Capitalize on market tailwinds in focus sectors (semi super cycle, IoT, electric vehicle and consumer)
• Extend leadership in thermal via Ambrell
• Grow market share and further broaden customer base in key markets
• Continued expanding market opportunity via M&A (customers, adjacent products, geographies)
END MARKETS SERVED
• ATE
• Automotive
• Defense/Aerospace
• Industrial Manufacturing
• Industrial Equipment
• Telecommunications
InTEST_2017AR_PR.indd 1
4/30/18 1:22 PM
Page 2 I inTEST I 2017 Annual Report
inTEST I 2017 Annual Report I Page 3
Fellow
Stockholders
Not Just Semi… Fueling Semiconductor
& Thermal Growth Markets
diversified, broad-range, expanded
product offering for non-traditional
electronics markets that require
thermal testing and conditioning.
We make things hot and cold where
it matters, leveraging our expertise
into a world-class thermal solutions
provider that plays a key enabling
role in new value-solutions for our
global customer base.
By all measures 2017 was an
outstanding year, further demonstrating
our strong execution and operating
leverage. Each of our business units
is fueling the growth we are experi-
encing from increasingly strong end
market demand. Non-semi business
drivers included solid advances
in the automotive, telecom, and
defense/aerospace markets, while
automotive sensors, mobility and IoT
led our semiconductor business.
We are very proud to have reported
our 8th consecutive year of profit-
ability, which speaks to the discipline
and dedication exhibited by every
inTEST employee. We continue to
make technology investments that
have led to new markets, as well
as revenue and margin expansion.
Ambrell Corporation, our most recent
acquisition, is making immediate
contributions. Ambrell’s induction
heating technology complements
our current thermal technologies
and firmly establishes our position
in industrial markets with a diverse
customer base in a broader manufac-
turing space, including in emerging
markets, consumer product packaging,
fiber-optic, automotive and other
markets. We have broadened our
customer diversification, lessening our
dependence on the highly cyclical
semiconductor market and increasing
our presence in growth markets. And
we have positioned the Company
to successfully deliver profits and
generate cash, even during cyclical
and seasonal ATE downturns.
• 2017 net revenues of $66.8 million
increased 66% compared to 2016
net revenues of $40.2 million.
2017 net revenues excluding
Ambrell were $53.2 million, a
32% increase compared to 2016.
• 2017 gross margin of $34.7
million increased 70% compared
to 2016 gross margin of $20.4
million. As a percentage of
revenue, 2017 gross margin of
52% increased 120 basis points
compared to 2016 gross margin
of 51%. Excluding the impact of
Ambrell, 2017 gross margin was
$28.1 million or 53%, an increase
of 38% year-over-year in absolute
dollars and 210 basis points as a
percentage of revenue.
• 2017 net earnings (GAAP) were
$1.0 million, a decrease of 63%,
compared to 2016 net earnings
of $2.7 million. 2017 earnings
per diluted share of $0.09
decreased $0.17 compared to
$0.26 reported in 2016. 2017
net earnings (GAAP) and net
earnings per diluted share (GAAP)
include the impact of a $7.0 million
Things are heating up at inTEST. 2017
was marked by a strategic acquisi-
tion, organic growth and a continued
focus on new product innovation. A
broad set of emerging market trends
such as Internet of Things (IoT), Big
Data, and autonomous vehicles is
accelerating the transformative era
of semiconductors and semiconductor
processing technologies, which has
fundamentally changed the way
we live, driving solid growth and
affording significant opportunities. By
continually responding to the dramatic
changes that accompany these market
trends, we better position ourselves to
meet the needs of our customers as
their technological roadmaps evolve.
We are not just Semi anymore.
Our business model is centered on
our core market in semiconductor
Automatic Test Equipment (ATE),
complemented by an increasingly
InTEST_2017AR_PR_5818.indd 2
5/8/18 11:27 AM
Page 2 I inTEST I 2017 Annual Report
inTEST I 2017 Annual Report I Page 3
increase in the liability for contingent
consideration related to an earn-out
payment for Ambrell.
• 2017 adjusted net earnings
(non-GAAP) were $9.1 million,
an increase of 218% compared
to 2016 adjusted net earnings
(non-GAAP) of $2.9 million. 2017
adjusted earnings per diluted share
(non-GAAP) of $0.88 increased
$0.60 compared to $0.28 reported
in 2016*.
These outstanding results demonstrate
the dedication that runs throughout our
organization to serving our customers
and delivering results to our stock-
holders, as well as the long-term value
generated in successful execution of
the Company’s strategic objectives.
We see significant opportunities
for growth. We are in an era of
technological change, with disruptive
technologies that are growing at
higher rates than traditional markets,
driven by a quest for manufacturing
efficiencies, the flow of data, connec-
tivity and mobility. The automotive
industry is one example where these
technologies converge, providing
opportunities for each inTEST business
to meet the challenges inherent to the
test and process industries.
Through a series of strategic moves
over several years, we have re-shaped
our business model. While we are
ensuring the foundation for inTEST’s
continued success through our focus on
maximizing the financial performance
of our core business, we also remain
committed to our goal of diversified
growth through acquisition. To that
end, we are actively pursuing syner-
gistic acquisition opportunities that
complement our current products and
expertise. We have transformed inTEST
largely through acquisitions, most
notably in our inTEST Thermal Solutions
division, and plan to continue to do
so in the future. Since 1998, we have
added six companies to our operations,
and approximately 81% of our 2017
revenue was derived from those acqui-
sitions − a very successful track record
of acquisitions that has broadened our
growth opportunities.
inTEST has marked two very meaningful
transitions in 2017. Our founder and
Executive Chairman, Alyn R. Holt,
passed away on May 13 at the age of
79. Alyn served as inTEST’s Chairman
since the Company’s inception in
September 1981 and as CEO
from September 1981 to August
1998. We are deeply saddened
by the passing of our friend and
colleague. Alyn exemplified the true
entrepreneurial spirit, and provided
visionary leadership throughout his
nearly 40 years of service to inTEST.
On behalf of our Board of Directors,
management team and our associates,
we mark Alyn’s passing, celebrate his
life and extend our deepest sympathies
to his family.
Our former Executive Chairman,
President & CEO, Robert E.
Matthiessen, retired from his position
as President & CEO at the end of
2017, after leading the organization
for 20 years. Bob has expertly piloted
the Company to significant growth
and success during his tenure, leading
a talented management team in the
delivery of consistent returns to inTEST
stockholders. He will continue to serve
as inTEST’s Chairman of the Board,
and we are very pleased to have his
continued guidance.
We are laser focused and approach
challenges head-on, helping to shape
the future of global manufacturing.
Our long-term goals are to increase
InTEST_2017AR_PR_5718.indd 3
5/7/18 10:52 AM
20
15
10
5
0
60
50
40
30
20
10
0
Page 4 I inTEST I 2017 Annual Report
2017
REVENUE
(Dollars in Millions)
2017
NON-SEMI
AS % REV
$20
$15
$10
$5
$0
60%
50%
40%
30%
20%
10%
0%
Q1 Q2 Q3 Q4
Q1 Q2 Q3 Q4
penetration in electronics test
markets, establish new OEM
business based on existing
product and technical knowl-
edge, and develop business in
other markets by leveraging our
core competencies. We aim to
be a recognized authority on
extreme temperature environ-
ments and to provide highly
engineered, application-specific
test and conditioning solutions
with timely delivery, and
superior quality and reliability.
We are bolstered by the
momentum and strength of our
business, as well as the adoption
of our new products from a
wide range of customers. We
are well-positioned to capture
market share in the markets we
serve, while expanding inTEST’s
footprint in additional thermal
test and industrial markets. As
we continue to execute on our
differentiated product strategy,
we believe the conditions for our
long-term success remain firmly
in place and we are solidly on
track for a strong 2018.
We extend our sincere
appreciation and thanks to
our customers, employees,
stockholders and suppliers for
their continued trust, confidence
and support during the past
year. We remain committed to
maintaining the highest ethical
standards in our relationships
with employees, customers,
stockholders and the public at
large, and to exceeding our
customers’ expectations while
protecting stockholder value.
Sincerely,
James Pelrin
President & CEO
May 1, 2018
* For a reconciliation of GAAP to
Non-GAAP financial measures,
see Appendix A on the final
page of this report.
InTEST_2017AR_PR.indd 4
4/30/18 1:23 PM
FO RM 10-K
InTEST_2017AR_10K CV.indd 1
4/30/18 1:24 PM
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
(cid:1409)(cid:1409) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2017
OR
(cid:1407) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________________ to ___________________
Commission File Number 1-36117
inTEST Corporation
(Exact name of registrant as specified in its charter)
DELAWARE
(State or Other Jurisdiction of Incorporation or Organization)
22-2370659
(I.R.S. Employer Identification Number)
804 EAST GATE DRIVE, SUITE 200
MT. LAUREL, NEW JERSEY
(Address of Principal Executive Offices)
08054
(Zip Code)
Registrant's telephone number, including area code: (856) 505-8800
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Common Stock, par value $0.01 per share
Name of Each Exchange on Which Registered
NYSE American
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes (cid:1407) No (cid:1409)
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes (cid:1407) No (cid:1409)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days. Yes (cid:1409) No (cid:1407)
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes (cid:1409) No (cid:1407)
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will
not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in
Part III of this Form 10-K or any amendment to this Form 10-K. (cid:1407)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company, or emerging growth company. See definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer (cid:1407)
Non-accelerated filer (Do not check if a smaller reporting company) (cid:1407) Smaller reporting company (cid:1409)
Emerging growth company (cid:1407)
Accelerated filer (cid:1407)
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial account standards provided pursuant to Section 13(a) of the Exchange Act. (cid:1407)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes (cid:1407) No (cid:1409)
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price
at which the common equity was last sold on June 30, 2017 (the last business day of the registrant's most recently completed
second fiscal quarter), was: $57,738,020.
The number of shares outstanding of the registrant's Common Stock, as of March 16, 2018, was 10,473,558.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement of the Registrant for the Registrant's 2018 Annual Meeting of Stockholders, to be filed
with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Report, are
incorporated by reference into Part III of this Report.
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
INDEX
PART I
Page
Item 1. Business .............................................................................................................................................................................
Item 1A. Risk Factors .......................................................................................................................................................................
Item 1B. Unresolved Staff Comments ..............................................................................................................................................
Properties ...........................................................................................................................................................................
Item 2.
Item 3.
Legal Proceedings ..............................................................................................................................................................
Item 4. Mine Safety Disclosures ....................................................................................................................................................
3
14
19
20
20
20
PART II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities ......... 20
Item 6.
Selected Financial Data ..................................................................................................................................................... 21
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations ............................................. 22
Item 7A. Quantitative and Qualitative Disclosures About Market Risk ........................................................................................... 30
Financial Statements and Supplementary Data .................................................................................................................. 30
Item 8.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure ............................................ 30
Item 9A. Controls and Procedures .................................................................................................................................................... 30
Item 9B. Other Information .............................................................................................................................................................. 31
PART III
Item 10. Directors, Executive Officers and Corporate Governance ................................................................................................. 32
Item 11. Executive Compensation ................................................................................................................................................... 32
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters .......................... 32
Item 13. Certain Relationships and Related Transactions, and Director Independence ................................................................... 32
Item 14. Principal Accounting Fees and Services ............................................................................................................................ 33
PART IV
Item 15. Exhibits, Financial Statement Schedules ........................................................................................................................... 33
Item 16. Form 10-K Summary ......................................................................................................................................................... 33
Index to Exhibits ................................................................................................................................................................ 34
Signatures .......................................................................................................................................................................... 36
Index to Consolidated Financial Statements and Financial Statement Schedule ............................................................... 37
- 2 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Cautionary Statement Regarding Forward-Looking Statements
From time to time, we make written or oral "forward-looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements contained in our filings with the Securities and Exchange Commission (“SEC”)
(including this Report on Form 10-K), our annual report to stockholders and in other communications. These statements do not
convey historical information, but relate to predicted or potential future events, such as statements of our plans, strategies and
intentions, or our future performance or goals. Our forward-looking statements can often be identified by the use of forward-looking
terminology such as "believes," "expects," "intends," "may," "will," "should," "plans" or "anticipates" or similar terminology, and
include, but are not limited to, statements made in this Report regarding:
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
the possibility of future acquisitions or dispositions and the successful integration of any acquired operations;
the ability to borrow funds or raise capital to finance major potential acquisitions;
the success of our strategy to diversify our business by entering markets outside the semiconductor and automated test
equipment (“ATE”), markets, including the automotive, consumer electronics, defense/aerospace, energy, industrial,
telecommunications and other markets;
indications of a change in the market cycles in the semiconductor and ATE markets or other markets we serve;
developments and trends in the semiconductor and ATE markets;
competitive pricing pressures;
the development of new products and technologies by us or our competitors;
effects of exchange rate fluctuations;
general economic conditions both domestically and globally;
the anticipated market for our products;
the availability of materials used to manufacture our products;
the availability of and retention of key personnel;
net revenues generated by foreign subsidiaries;
the sufficiency of cash balances, lines of credit and net cash from operations;
stock price fluctuations; and
other projections of net revenues, taxable earnings (loss), net earnings (loss), net earnings (loss) per share, capital
expenditures and other financial items.
Investors and prospective investors are cautioned that such forward-looking statements are only projections based on current
estimations. These statements involve risks and uncertainties and are based upon various assumptions. We discuss many of these
risks and uncertainties under Item 1A "Risk Factors," below, and elsewhere in this Report. These risks and uncertainties, among
others, could cause our actual future results to differ materially from those described in our forward-looking statements or from our
prior results. We are not obligated to update these forward-looking statements, even though our situation may change in the future.
PART I
Item 1. BUSINESS
INTRODUCTION
In this report, "we," "us," "our," and the "Company" refer to inTEST Corporation and its consolidated subsidiaries. We are an
independent designer, manufacturer and marketer of thermal management products and ATE interface solutions which are used
by semiconductor manufacturers to perform development, qualifying and final testing of integrated circuits (“ICs”) and wafers,
and for other electronic test across a range of industries including the automotive, defense/aerospace, energy, industrial,
telecommunications and other markets. We also offer induction heating products for joining and forming metals in a variety of
industrial markets, including automotive, aerospace, machinery, wire & fasteners, medical, semiconductor, food & beverage,
and packaging. Our high-performance products are designed to enable our customers to improve the efficiency of their test and
manufacturing processes and, consequently, their profitability.
- 3 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
We sell our products worldwide. Within the ATE market, we sell our products both directly to major semiconductor
manufacturers and semiconductor test subcontractors and indirectly through leading ATE manufacturers. In markets outside the
ATE market, we sell our products directly to the end user of the product. Our largest customers include Analog Devices, Inc.,
Cypress Semiconductor Corporation, Foxconn Optical Interconnect Technologies, Inc., Hakuto Co. Ltd., NaigaiTEC
Corporation, NXP Semiconductors N.V., Rosendahl Nextrom GmbH, STMicroelectonics N.V., Teradyne, Inc. and Texas
Instruments Incorporated.
The consolidated entity is comprised of inTEST Corporation (parent) and our wholly-owned subsidiaries. inTEST Corporation
was incorporated in New Jersey in 1981 and reincorporated in Delaware in April 1997. During 2016, we reorganized our
business from three product segments, Thermal Products, Mechanical Products and Electrical Products, into two product
segments, Thermal Products ("Thermal") and Electromechanical Semiconductor Products ("EMS"). Accordingly, effective
January 1, 2017, we have two reportable segments, which are also our reporting units. Prior period information has been
reclassified to be comparable to the presentation for 2017.
On May 24, 2017, we completed the acquisition of Ambrell Corporation ("Ambrell") for $22.0 million in cash. The acquisition
was completed by acquiring all of the outstanding capital stock of Ambrell. Ambrell is a manufacturer of precision induction
heating systems which are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically
conductive materials, in order to transform raw materials into finished parts. The Ambrell acquisition complements our current
thermal technologies and broadens our diverse customer base, allowing expansion within many non-semiconductor related
markets, such as consumer product packaging, fiber-optics, automotive and other markets. Ambrell's operations are included in
our Thermal segment. Ambrell manufactures its products in the U.S. and conducts marketing and support activities from its
facilities in the U.S., the Netherlands and the U.K. This acquisition is discussed further in Note 3 to our consolidated financial
statements included in Item 8 of this Report on Form 10-K.
MARKETS
Overview
Our business is grounded in the ATE market, which provides automated test equipment to the semiconductor market. While the
ATE market remains a key driver in our business, since 2009, we have taken actions to diversify our served markets to address
the thermal test requirements of several other markets outside the semiconductor market as well as certain thermal process
industrial requirements. The markets we have targeted outside the semiconductor market include the automotive, consumer
electronics, defense/aerospace, energy, industrial and telecommunications markets. Prior to the acquisition of Ambrell in May
2017, as discussed above, we offered only highly specialized engineering solutions in these markets outside the semiconductor
market, the demand for which is limited and which we expect may vary significantly from period to period. Ambrell sells its
precision induction heating systems almost exclusively to customers in the industrial market, which is a non-semiconductor
market. We expect that the acquisition of Ambrell will significantly reduce our dependence on customers in the semiconductor
market. We expect that our future orders and net revenues will be approximately equally split between the semiconductor and
non-semiconductor markets. During 2017 and 2016, our net revenues in markets outside the semiconductor market were $29.0
million (including $13.2 million of net revenues attributable to Ambrell) and $12.2 million, respectively, and represented 44%
and 30%, respectively, of our total net revenues. In the last five years, our net revenues from sales in markets outside the
semiconductor market have ranged from 27% to 44%.
The level of our net revenues in the various markets we serve outside the semiconductor market varies significantly from
market to market. During 2017 and 2016, our net revenues from the telecommunications market represented 15% of our total
net revenues for both years, while our net revenues from the defense/aerospace market represented 5% and 8%, respectively, of
our total net revenues and our net revenues from the industrial market represented 21% and 2%, respectively, of our total net
revenues. The level of our net revenues in these non-semiconductor markets has varied significantly in the past and we expect
will vary significantly in the future as we build our presence in these markets and establish new markets for our products. One
of our goals is to further expand our sales in these markets outside the semiconductor market; however, due to the highly
specialized nature of many of our product offerings in these non-semiconductor markets, we do not expect broad market
penetration in many of these markets and therefore, do not anticipate developing meaningful market shares in these non-
semiconductor markets. Consequently, we are continuing to evaluate buying patterns and opportunities for growth in these
markets that may affect our performance.
- 4 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
The one non-semiconductor market where we believe we have developed a meaningful market share is the optical transceiver
market, which is a submarket to the broad telecommunications market. In contrast to the semiconductor or ATE markets where
we serve a broad range of customers and where our business trends follow the overall market trends within the semiconductor
or ATE markets, in the optical transceiver submarket, we only serve those companies producing high speed transceiver devices,
which represent only a portion of that submarket, and therefore, optical transceiver submarket trends do not have a similar
material impact on our financial results. The following discussion of our markets, therefore, is limited to only the ATE and
semiconductor markets, which currently represent the majority of our net revenues.
Semiconductor and ATE Markets
Historically, the semiconductor market has been characterized by rapid technological change, wide fluctuations in demand and
shortening product life cycles. Designers and manufacturers of a variety of electronic and industrial products, such as cell
phones, telecom and datacom systems, Internet access devices, computers, transportation and consumer electronics, require
increasingly complex ICs to provide improved end-product performance demanded by their customers. Semiconductor
manufacturers generally compete based on product performance and price. We believe that testing costs represent a significant
portion of the total cost of manufacturing ICs. Semiconductor manufacturers remain under pressure to maximize production
yields and reduce testing costs. At the same time, the growing complexity of ICs has increased the difficulty of maximizing test
yields. In order to address these market trends, semiconductor manufacturers strive for more effective utilization of ATE, smaller
test areas and increased wafer level testing.
Demand for new ATE and related equipment depends upon several factors, including the demand for products that incorporate
ICs, the increasing complexity of ICs and the emergence of new IC design, production and packaging technologies. Some of the
evolutionary changes in IC technologies included the shift to 300 mm wafers in production, system-on-a-chip (“SOC”) where
digital, analog and memory functions are combined on a single IC, and chip scale packaging. As a result of these and other
advances, semiconductor manufacturers may require additional ATE not only to handle increases in production but also to handle
the more sophisticated testing requirements of ICs.
IC Test Process
Semiconductor manufacturers typically produce ICs in multiples of several hundred on a silicon wafer which is later separated or
"diced" into individual ICs. Extended leads are then attached to the individual ICs for later connection to other electrical
components. In most cases, the ICs are then encapsulated in a plastic, ceramic or other protective housing. These process steps
are called "packaging."
Wafers are tested before being diced and packaged, to ensure that only properly functioning ICs are packaged. This testing step
has several names, including "front-end test," "wafer test," "wafer probe" or "wafer sort." In front-end test, an electronic handling
device known as a wafer prober automatically positions the wafer under a probe card which is electronically connected to a "test
head," which connects electrically to a test system. During front-end testing, there is a growing trend of thermally conditioning
the wafer during test. Once the good ICs have been identified, they are packaged.
The packaged ICs also require testing, called "back-end test" or "final test," to determine if they meet design and performance
specifications. Packaged ICs are tested after loading into another type of electronic handling device called a "package handler" or
"handler," which then transfers the packaged ICs into a test socket which is attached to the test head. These handlers may be
temperature controlled for testing. "Wafer probers" and "handlers" are sometimes referred to in this Report collectively as
"electronic device handlers."
Testers range in price from approximately $100,000 to over $2.0 million each, depending primarily on the complexity of the IC
to be tested. Probers and handlers range in price from approximately $50,000 to $500,000. A typical test floor of a large
semiconductor manufacturer may have 100 test heads and 100 probers or 250 handlers supplied by various vendors for use at any
one time. While larger global semiconductor manufacturers typically purchase ATE to test the ICs they manufacture, there are a
growing number of semiconductor manufacturers who outsource IC testing to third-party foundries, test and assembly providers.
- 5 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
Test head manipulators, also referred to as positioners, facilitate the movement of the test head to the electronic device handler.
Docking hardware mechanically connects the test head to the wafer prober or handler. Tester interface products provide the
electrical connection between the test head and the wafer or packaged IC. Traditionally, temperature management products are
used in back-end test to allow a manufacturer to test packaged ICs under the extreme temperature conditions in which the IC may
be required to operate. However, we believe that temperature-controlled testing will be an increasingly important part of front-
end wafer testing as more parameters traditionally tested in back end-test are moved to front-end test.
Trends in IC Testing
ATE is used to identify unacceptable packaged ICs and bad die on wafers. ATE assists IC manufacturers in controlling test costs
by performing IC testing in an efficient and cost-effective manner. In order to provide testing equipment that can help IC
manufacturers meet these goals, we believe the ATE market must address the following issues:
Change in Technology. End-user applications are demanding ICs with increasingly higher performance, greater speeds, and
smaller sizes. ICs that meet these higher standards, including SOC designs, are more complex and dense. These technology
trends have significant implications for the IC testing process, including:
the need for test heads of higher complexity;
●
● higher signal densities;
●
●
increasing test speeds; and
a new generation of testers for SOC and other technologies.
Need for Plug-Compatibility and Integration. Semiconductor manufacturers need test methodologies that will perform
increasingly complex tests while lowering the overall cost of testing. This can require combining ATE manufactured by various
companies into optimally performing systems. Semiconductor manufacturers have to work closely with various test hardware,
software, interface and component vendors to resolve design and compatibility issues in order to make these vendors' products
plug-compatible with test equipment manufactured by other vendors.
Testing Under Extreme Conditions. ICs will have to perform across a wider spectrum of temperature and environmental
conditions than ever before because of the growing complexity of products in which they are deployed. In recent years,
temperature testing has found an increasing role in front-end, wafer-level testing. Creating a uniform thermal profile over much
larger wafer areas represents a significant engineering and design challenge for ATE manufacturers.
Demand for Higher Levels of Technical Support. As IC testing becomes more complex, semiconductor manufacturers demand
higher levels of technical support on a routine basis. ATE manufacturers must commit appropriate resources to technical
support in order to develop close working relationships with their customers. This level of support also requires close proximity
of service and support personnel to customers' facilities.
Cost Reduction Through Increased Front-End Testing. As the cost of testing ICs increases, semiconductor manufacturers will
continue to look for ways to streamline the testing process to make it more cost-effective, such as the trend to use massive
parallel testing, in which semiconductor manufacturers test multiple ICs on the wafer simultaneously. We believe that this
factor will lead to more front-end, wafer-level testing.
OUR SOLUTIONS
Historically, we have focused our development efforts on designing and producing high quality products that provide superior
performance and cost-effectiveness. We have sought to address each manufacturer's individual needs through innovative and
customized designs, use of the best materials available, quality manufacturing practices and personalized service. We have
designed solutions to overcome the evolving challenges facing the ATE market and other markets that we serve, which we
believe provide the following advantages:
- 6 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
Temperature-Controlled Testing. Our Thermostream(R) products are used by manufacturers in a number of markets to stress test
a variety of semiconductor and electronic components, printed circuit boards and sub-assemblies. Our Thermochuck(R) products
are used by semiconductor manufacturers for front-end temperature stress screening at the wafer level. Factors motivating
manufacturers to use temperature testing include design characterization, failure analysis and quality control as well as
determining performance under extreme operating temperatures, all of which contribute to manufacturing cost savings. Our
acquisitions of Sigma Systems Corporation ("Sigma"), in October 2008, and Thermonics, Inc. ("Thermonics"), in January 2012,
have significantly increased our product offerings in the area of temperature-controlled testing and enabled us to begin serving
customers in other markets outside the ATE market. Sigma's thermal platforms and temperature chambers can accommodate
large thermal masses and are found in both laboratory and production environments. Thermonics' products provide a range of
precision temperature forcing systems and have been melded into Temptronic's ATS ThermoStream product line. The
Thermonics brand is now used to market a family of process chillers for test and industrial applications.
Induction Heating Applications. Our acquisition of Ambrell added induction heating capabilities to our product offerings, which
can be used by customers in process applications where precision controlled heating is needed. Customers use our induction
heating products in conjunction with other technologies in various manufacturing environments to improve production
efficiencies. Applications for our EKOHEAT(R) or EASYHEATTM induction heating products include annealing, bonding,
brazing, curing, forging, heat treating, melting, shrink-fitting and testing.
Scalable, Universal, High Performance Interface Technology. Our universal test head manipulators provide a high degree of
positioning flexibility with a minimum amount of effort. As a result, our products can be used in virtually any test setting. Our
manipulator products are designed to accommodate the increased size of test heads. Our docking hardware offers precise control
over the connection to test sockets, probing assemblies and interface boards, reducing downtime and minimizing costly damage
to fragile components. Our tester interface products optimize the integrity of the signals transmitted between the test head and
the device under test by being virtually transparent to the test signals. This results in increased accuracy of the test data and may
thus enable improved test yields. We believe that these characteristics will gain even more significance as testing becomes even
more demanding.
Compatibility and Integration. A hallmark of our products has been, and continues to be, compatibility with a wide variety of
ATE. Our manipulator and docking hardware products are all designed to be used with otherwise incompatible ATE. We believe
this integrated approach to ATE facilitates smooth changeover from one tester to another, longer lives for interface components,
better test results, increased ATE utilization and lower overall test costs.
Worldwide Customer Service and Support. We have long recognized the need to maintain a physical presence near our
customers' facilities. As of December 31, 2017, we had domestic manufacturing facilities in California, Massachusetts, New
Jersey and New York and provided service to our customers from sales and service personnel based in the U.S., Europe and
Asia. Our engineers are easily accessible to, and can work directly with, most of our customers from the time we begin
developing our initial proposal, through the delivery, installation and use of the product by our customer. In this way, we are able
to develop and maintain close relationships with our customers.
OUR STRATEGIES
We remain committed to our goals of being recognized in our markets as the designer and manufacturer of the highest quality
and most cost-effective products and becoming the key supplier of all of our customers' product needs. Our strategies to achieve
these goals include the following:
Pursuing Synergistic Acquisitions. A key element of our growth strategy has been to acquire businesses, technologies or products
that are complementary to our current product offerings. Since our initial public offering in 1997, we have acquired several
businesses which have enabled us to expand our line of product offerings and have given us the opportunity to market a broader
range of products to our customer base. In particular, the acquisitions of Temptronic in 2000, Sigma in 2008, Thermonics in 2012
and Ambrell in 2017 have provided access to markets that are less sensitive to cyclicality than the semiconductor market. We
seek to make acquisitions that will further expand our product lines as well as increase our exposure to markets outside of the
semiconductor market.
- 7 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
Pursuing Revenue Growth Opportunities Outside the Semiconductor ATE Market. Another element of our growth strategy is to
pursue revenue growth opportunities in markets we have not traditionally served, such as the automotive, consumer electronics,
defense/aerospace, energy, industrial and telecommunications markets. We believe that we may be able to reduce some of the
cyclicality that we have historically experienced by further diversifying our revenue streams outside the semiconductor ATE
market. We see the most potential for this within our Thermal segment. During 2017 and 2016, approximately $29.0 million
(including $13.2 million of net revenues attributable to Ambrell), or 44%, and $12.2 million, or 30%, respectively, of our total
net revenues were derived from markets outside semiconductor. These revenues were all generated by our Thermal segment. We
cannot determine at this time whether we will be successful in building our sales in these non-traditional markets or what the
growth rate of our sales in these markets will be in future periods.
Providing Technologically Advanced Solutions. We are committed to designing and producing only the highest quality products
which incorporate innovative designs to achieve optimal cost-effectiveness and functionality for each customer's particular
situation. Our engineering and design staff is continually engaged in developing new and improved products and manufacturing
processes.
Leveraging Our Strong Customer Relationships. Our technical personnel work closely with ATE manufacturers to design tester
interface and docking hardware that are compatible with their ATE. As a result, we are often privy to proprietary technical data
and information about these manufacturers' products. We believe that because we do not compete with ATE manufacturers in the
prober, handler and tester markets, we have been able to establish strong collaborative relationships with these manufacturers that
enable us to develop ancillary ATE products on an accelerated basis. Engineering is also at the heart of the thermal segment
where customers often return to inTEST with their next thermal challenge. We work to cement relationships with customers that
have demanding specifications whether it be thermal testing at temperature extremes for aerospace application, for example, or
delivering precise heating for efficient industrial processes. We believe that with our capabilities to consistently demonstrate
solutions from proof of concept to manufactured products with required specifications, we can continue to strengthen our
customer relationships.
Maintaining Our International Presence. Our existing and potential customers are concentrated in certain regions throughout the
world. We believe that we must maintain a presence in the markets in which our customers operate. We currently have offices in
the U.S., Germany, Singapore, the Netherlands and the U.K.
Controlling Costs. At the same time as we are pursuing growth opportunities, we will seek ways to more aggressively streamline
our cost structure, so that we are positioned to offer products at prices that provide the margin for a reasonable profit as well as
the resources for continual product development.
OUR SEGMENTS
In 2016, we reorganized our business from three product segments, Thermal Products, Mechanical Products and Electrical
Products, into two product segments, Thermal and Electromechanical Semiconductor ("EMS"). Accordingly, effective January 1,
2017, we have two reportable segments, which are also our reporting units. Prior period information has been reclassified to be
comparable to the presentation for 2017.
Our Thermal segment consists of inTEST Thermal Solutions (“iTS”) which manufactures and sells products under the
Temptronic, Sigma and Thermonics brand names and Ambrell, which we acquired in May 2017, as discussed above. iTS has
operations in Massachusetts, Germany and Singapore. Ambrell has operations in New York, the Netherlands and the U.K.
Customers use the thermal solutions produced by iTS for product development, characterization and production test
applications. Ambrell provides customers with induction heating system solutions for conditioning, joining, and forming
conductive materials in the manufacturing process. Our Thermal segment provides these solutions across an array of industries
including automotive, consumer electronics, defense/aerospace, energy, industrial, semiconductor and telecommunications
markets.
Our EMS segment consists of our manufacturing operations in New Jersey and California. Semiconductor manufacturers use
our EMS solutions in back-end testing where our mechanical and electrical products serve production testing of wafers and
specialized packaged ICs. These ICs include microprocessors, digital signal processing chips, mixed signal devices, MEMS
(Micro-Electro-Mechanical Systems), application specific ICs and specialized memory ICs, and are used primarily in the
automotive, consumer electronics, defense/aerospace, energy, industrial and telecommunications markets. We custom design
most of our products for each customer's particular combination of ATE.
- 8 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
Thermal Products
Our thermal products are sold into the environmental test market encompassing a wide variety of markets including the ATE,
automotive, consumer electronics, defense/aerospace, energy, industrial and telecommunications markets. Our thermal products
enable a manufacturer to test semiconductor wafers and ICs, electronic components and assemblies, mechanical assemblies and
electromechanical assemblies. Our thermal products provide the ability to characterize and stress test a variety of materials over
extreme and variable temperature conditions that can occur in actual use.
ThermoStream(R) Products: Our ThermoStream(R) products are used in the semiconductor market as a stand-alone temperature
management tool, or in a variety of electronic test applications as part of our MobileTemp systems. ThermoStream(R) products
provide a source of heated and cooled air which can be directed over the component or device under test. These systems are
capable of controlling temperatures to within +/- 0.1 degree Celsius over a range of -100 degrees Celsius to as high as +300
degrees Celsius within 1.0 degree Celsius of accuracy. As a stand-alone tool, ThermoStreams(R) provide a temperature-
controlled air stream to rapidly change and stabilize the temperature of packaged ICs and other devices.
Our MobileTemp Series combines our ThermoStream(R) products with our family of exclusive, high-speed ThermoChambers to
offer thermal test systems with fast, uniform temperature control in a compact package enabling temperature testing at the test
location. MobileTemp Systems are designed specifically for small thermal-mass applications beyond the semiconductor market
and have found application in the automotive, electronic, fiber optic and oil field service markets testing such things as
electronic sub-assemblies, sensor assemblies, and printed circuit boards.
Traditionally, our customers used ThermoStream(R) products primarily in engineering, quality assurance and small-run
manufacturing environments. However, increasingly, our customers use ThermoStream(R) products in longer-run production
applications. ThermoStream(R) and MobileTemp products range in price from approximately $15,000 to $50,000.
ThermoChambers: Our chamber products are available in a variety of sizes, from small bench-top units to chambers with
internal volumes of twenty-seven cubic feet and greater and with temperature ranges as wide as from -190 degrees Celsius to
+500 degrees Celsius. Chambers can be designed to utilize liquid nitrogen or liquid carbon dioxide cooling or mechanical
refrigeration, and sometimes both. These chambers can accommodate large thermal masses and are found in both laboratory and
production environments. Chambers are priced from $15,000 to $150,000.
Thermal Platforms: Our platforms are available in surface sizes ranging from 7.2 square inches to 616 square inches. They
provide a flat, thermally conductive, precisely temperature controllable surface that is ideal for conditioning of testing devices
with a flat surface. Platforms are available with temperature ranges as broad as -100 degrees Celsius to +250 degrees Celsius.
Thermal platforms can be designed to utilize either liquid nitrogen or liquid carbon dioxide cooling or mechanical refrigeration.
Platforms offer virtually unimpeded access to the device under test and their easy access and compact size makes them ideal for
convenient bench-top use. Platforms are priced from $6,500 to $65,000.
ThermoChuck(R) Products: Our ThermoChuck(R) precision vacuum platform assemblies, used primarily in the semiconductor
market, quickly change and stabilize the temperature of semiconductor wafers accurately and uniformly during testing without
removing the wafer from its testing environment. Such temperatures can range from as low as -65 degrees Celsius to as high as
+300 degrees Celsius. ThermoChucks(R) are incorporated into wafer prober equipment for laboratory analysis and for in-line
production testing of semiconductor wafers. ThermoChuck(R) products range in price from approximately $25,000 to $120,000.
Thermonics(R) Products: Our Thermonics temperature conditioning products provide tempered gas or fluid to enable customers
to maintain desired thermal conditions within their tool or process. Applications include general industrial, chemical processing,
energy, electronics, automotive, mil/aero and semiconductor markets. Prices range from $20,000 to greater than $200,000.
EKOHEAT(R) Products: Our EKOHEAT(R) induction heating systems with power ratings from 10KW to 500KW are
manufactured by Ambrell and are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically
conductive materials, in order to transform raw materials into finished parts. Prices range from $25,000 to $250,000.
EASYHEAT™ Products: Our compact EASYHEATTM induction heating systems with power ratings from 1KW to 10KW are
manufactured by Ambrell are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically
conductive materials, in order to transform raw materials into finished parts. Prices range from $5,000 to $25,000.
- 9 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
EASYHEAT™ Products: Our compact EASYHEATTM induction heating systems with power ratings from 1KW to 10KW are
manufactured by Ambrell are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically
conductive materials, in order to transform raw materials into finished parts. Prices range from $5,000 to $25,000.
Applications for both EKOHEAT(R) and EASYHEATTM products include annealing, bonding, brazing, curing, forging, heat
treating, melting, shrink-fitting, soldering and testing.
EMS Products
Manipulator Products. We offer two lines of manipulator products: the in2(R) and the Cobal Series. These free-standing
universal manipulators can hold a variety of test heads and enable an operator to reposition a test head for alternate use with any
one of several probers or handlers on a test floor.
The in2(R) and Cobal Series of manipulator products incorporate our balanced floating-head design. This design permits a test
head weighing up to 1,100 pounds to be held in an effectively weightless state, so it can be moved manually or with optional
powered assistance, up or down, right or left, forward or backward and rotated around each axis (known as six degrees of
motion freedom) by an operator using a modest amount of force. The same design features enable the operator to dock the test
head without causing inadvertent damage to the fragile electrical contacts. As a result, after testing a particular production lot of
ICs, the operator can quickly and easily disconnect a test head that is held in an in2(R) manipulator and equipped with our
docking hardware and dock it to another electronic device handler for testing either a subsequent lot of the same packaged ICs
or to test different ICs. The in2(R) and Cobal Series manipulators range in price from approximately $12,000 to $60,000.
Docking Hardware Products. We offer two lines of docking hardware products: fixed manual docking and Intellidock pin and
cup docking. Both types protect the delicate interface contacts and ensure proper repeatable and precise alignment between the
test head's interface board and the prober's probing assembly or the handler's test socket as they are brought together, or
"docked." Fixed manual docking includes a mechanical cam mechanism to dock and lock the test head to the prober or handler.
Intellidock is an automated docking solution that provides operator feedback for each docking step via a touchscreen display.
Both types eliminate motion of the test head relative to the prober or handler. This minimizes deterioration of the interface
boards, test sockets and probing assemblies which is caused by constant vibration during testing. Our docking hardware
products are used primarily with floating-head universal manipulators when maximum mobility and inter-changeability of
handlers and probers between test heads is required. By using our docking hardware products, semiconductor manufacturers can
achieve cost savings through improved ATE utilization, improved accuracy and integrity of test results, and reduced repairs and
replacements of expensive ATE interface products.
We believe our docking hardware products offer our customers the ability to make various competing brands of test heads
compatible with various brands of probers and handlers by only changing interface boards. This is called "plug-compatibility."
Plug-compatibility enables increased flexibility and utilization of test heads, probers and handlers purchased from various ATE
manufacturers. We believe that because we do not compete with ATE manufacturers in the sale of probers, handlers or testers,
ATE manufacturers are willing to provide us with the information that is integral to the design of plug-compatible products. Our
docking hardware products range in price from approximately $2,000 to $25,000.
Interface Products. Our tester interface products provide the electrical connections between the tester and the wafer prober or
IC handler to carry the electrical signals between the tester and the probe card on the prober or the test socket on the handler.
Our designs optimize the integrity of the transmitted signal. Therefore, our tester interfaces can be used with high speed, high
frequency, digital or mixed signal testers used in testing more complex ICs. Because our tester interface products enable the
tester to provide more reliable yield data, our interfaces may also reduce IC production costs. We design standard and modular
interface products to address most possible tester/prober combinations on the market today. In addition, we provide a custom
design service that will allow any of our customers to use virtually any tester, prober or handler combination with any type of
device, such as analog, digital, mixed signal and radio frequency. For example, our Centaur(R) modular interface is designed to
provide flexibility and scalability through the use of replaceable signal modules which can be easily changed on the test floor as
our customers' testing requirements change. In addition to the Centaur(R) modular interface, we also offer over 200 different
types of tester interface models that we custom designed for our customers' specific applications. These tester interface products
range in price from approximately $7,000 to $110,000.
- 10 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
Financial Information About Product Segments and Geographic Areas
Please see Note 16 of our consolidated financial statements included in Item 8 of this Report on Form 10-K for additional data
regarding net revenues, profit or loss and total assets of each of our segments and revenues attributable to foreign countries.
MARKETING, SALES AND CUSTOMER SUPPORT
We market and sell our products primarily in markets where semiconductors are manufactured. North American and European
semiconductor manufacturers, as well as third-party foundries, test and assembly providers, have located most of their back-
end factories in Southeast Asia. The front-end wafer fabrication plants of U.S. semiconductor manufacturers are primarily in
the U.S. Likewise, European, Taiwanese, South Korean and Japanese semiconductor manufacturers generally have located
their wafer fabrication plants in their respective countries. We have been providing a greater number of engineered solutions
to non-semiconductor markets. These are thermal-based solutions that fall into the categories of test and process, involving
automotive, consumer electronics, defense/aerospace, energy, industrial and telecommunications markets.
Thermal Products: We market our thermal products brands, Temptronic, Sigma and Thermonics, under the umbrella name of
inTEST Thermal Solutions and sales to ATE manufacturers are handled directly by our own sales force. Sales to
semiconductor manufacturers and customers in other markets in the U.S. are handled through independent sales representative
organizations. In Singapore and Malaysia, our sales and service are handled through our internal sales and service staff. In the
rest of Asia, our sales are handled through distributors. In Europe, sales managers at our office in Germany, as well as
regional distributors and independent sales representatives, sell to semiconductor manufacturers and customers in other
markets. We visit our distributors regularly and have trained them to sell and service our thermal products.
We market our EASYHEATTM and EKOHEAT(R) precision induction heating equipment to manufacturers who require
specialized industrial heating in a wide array of industries including automotive, aerospace and semiconductor and are sold
globally through a combination of regional sales and strategic account managers and independent distributors. In North
America and Europe, direct regional sales managers provide sales coverage augmented by distributors in Mexico and three
European countries. Our strategic account managers cover targeted segments and create and manage relationships with key
management personnel. In Asia, seven distributors have responsibility for sales and service of our products.
We also provide induction heating product support through our SmartCARE Service offering, which includes equipment
repairs and training, preventative maintenance, enhanced warranties and spare parts. Our field service engineers, located in the
U.S. and Europe, provide service and support globally. Additionally, a number of distributors in North America, Europe and
Asia have factory-trained service technicians.
EMS Products: In North America, we sell to semiconductor manufacturers principally through the use of independent,
commissioned sales representatives. North American sales representatives also coordinate product installation and support
with our technical staff and participate in trade shows.
Our internal sales account managers handle sales to ATE manufacturers and are responsible for a portfolio of customer
accounts and for managing certain independent sales representatives. In addition, our sales account managers are responsible
for pricing, quotations, proposals and transaction negotiations, and they assist with applications engineering and custom
product design. Technical support is provided to North American customers and independent sales representatives by
employees based in New Jersey, California and Texas.
In Europe, we sell to semiconductor and ATE manufacturers through our internal sales staff. Technical support is provided by
our staff in the U.K. In China, Japan, the Philippines, South Korea, and Thailand, we sell through the use of independent sales
representatives who are supervised by our internal sales staff. In Malaysia, Singapore and Taiwan, our sales are handled by
our internal sales staff. International sales representatives are responsible for sales, installation, support and trade show
participation in their geographic market areas. Technical support is provided to Asian customers primarily by employees
based in Malaysia, the Philippines and Taiwan.
- 11 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
CUSTOMERS
We market all of our products to end users, which include semiconductor manufacturers and third-party foundries, test and
assembly providers, as well as to original equipment manufacturers ("OEMs"), which include ATE manufacturers and their
third-party outsource manufacturing partners. In the case of thermal products, we also market our products to independent
testers of semiconductors, manufacturers of automotive, consumer electronics, defense/aerospace, energy, industrial and
telecommunications products, semiconductor research facilities, and manufacturers and manufacturing process integrators for
a variety of industrial process applications. Our customers use our products principally in production testing, although our
ThermoStream(R) products traditionally have been used largely in engineering development and quality assurance. We believe
that we sell to most of the major semiconductor manufacturers in the world.
During the years ended December 31, 2017 and 2016, Hakuto Co. Ltd., one of our distributors, accounted for 11% and 13% of
our consolidated net revenues, respectively. These revenues were generated by our Thermal segment. During the years ended
December 31, 2017 and 2016, Texas Instruments Incorporated accounted for 11% and 10% of our consolidated net revenues,
respectively. While both of our operating segments sold products to this customer, these revenues were primarily generated by
our EMS segment. Our ten largest customers accounted for approximately 46% and 50% of our consolidated net revenues in
2017 and 2016, respectively. The loss of any one or more of our largest customers, or a reduction in orders by a major customer,
could materially reduce our net revenues or otherwise materially affect our business, financial condition or results of operations.
Our largest customers in 2017 include:
ATE Manufacturers
Teradyne, Inc.
Other
Foxconn Optical Interconnect Technologies, Inc.
Hakuto Co. Ltd.
Rosendahl Nextrom GmbH
Semiconductor Manufacturers
Analog Devices, Inc.
Cypress Semiconductor Corporation
NaigaiTEC Corporation
NXP Semiconductors N.V.
STMicroelectronics N.V.
Texas Instruments Incorporated
MANUFACTURING AND SUPPLY
As of December 31, 2017, our principal manufacturing operations consisted of assembly and testing at our facilities in
California, Massachusetts, New Jersey and New York. We assemble most of our products from a combination of standard
components and custom parts that have been fabricated to our specifications by either third-party manufacturers or our own
fabrication operation in New Jersey. Our practice is to use the highest quality raw materials and components in our products.
The primary raw materials used in fabricated parts are all widely available. We purchase substantially all of our components
from multiple suppliers. We purchase certain raw materials and components from single suppliers, however, we believe that all
materials and components are available in adequate amounts from other sources, although from time to time, certain
components may be in short supply because of high demand or the inability of some vendors to consistently meet our quality or
delivery requirements.
We conduct inspections of incoming raw materials, fabricated parts and components using sophisticated measurement
equipment. This includes testing with coordinate measuring machines in all but one of our manufacturing facilities to ensure
that products with critical dimensions meet our specifications. We have designed our inspection standards to comply with
applicable MIL specifications and ANSI standards.
Our Massachusetts facility is ISO 9001:2015 certified. Our New York facility is ISO 9001:2008 certified. Our New Jersey and
California facilities manufacture products only for the semiconductor industry where ISO certification is not required. However,
these locations do employ the practices embodied in the ISO 9001:2008.
ENGINEERING AND PRODUCT DEVELOPMENT
Our success depends on our ability to provide our customers with products and solutions that are well engineered, and to design
those products and solutions before, or at least no later than, our competitors. As of December 31, 2017, we employed a total of
42 engineers, who were engaged in engineering and product development. In addition, when the demands of engineering and
- 12 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
product development projects exceed the capacity or knowledge of our in-house staff, we retain temporary third-party
engineering and product development consultants to assist us. Our practice in many cases is to assign engineers to work with
specific customers, thereby enabling us to develop the relationships and exchange of information that is most conducive to
successful product development and enhancement. In addition, some of our engineers are assigned to new product research and
development and have worked on such projects as the development of new types of universal manipulators, the redesign and
development of new thermal products and the development of high performance interfaces.
Since most of our products are customized, we consider substantially all of our engineering activities to be engineering and
product development. We spent approximately $4.3 million in 2017 and $3.7 million in 2016 on engineering and product
development. 2017 expenses include $650,000 attributable to Ambrell, which we acquired in May 2017.
PATENTS AND OTHER PROPRIETARY RIGHTS
Our policy is to protect our technology by filing patent applications for the technologies that we consider important to our
business. We also rely on trademarks, trade secrets, copyrights and unpatented know-how to protect our proprietary rights. It is
our practice to require that all of our employees and third-party product development consultants assign to us all rights to
inventions or other discoveries relating to our business that were made while working for us. In addition, all employees and
third-party product development consultants agree not to disclose any private or confidential information relating to our
technology, trade secrets or intellectual property.
As of December 31, 2017, we held 79 active U.S. patents and had 7 pending U.S. patent applications covering various aspects
of our technology. Our acquisition of Ambrell during 2017 provided 30 of those US patents, as well as 1 US patent application.
Our U.S. patents expire at various times beginning in 2018 and extending through 2035. During 2017, one U.S. patent was
issued and we had two U.S. patents expire. We do not believe that the upcoming expiration of certain of our patents in 2018 will
have a material impact on our business. We also hold foreign patents and file foreign patent applications, in selected cases
corresponding to our U.S. patents and patent applications, to the extent management deems appropriate.
While we believe that our patents and other proprietary rights are important to our business, we also believe that, due to the
rapid pace of technological change in the semiconductor equipment market, the successful manufacture and sale of our products
also depends upon our engineering, manufacturing, marketing and servicing skills. In the absence of patent protection, we
would be vulnerable to competitors who attempt to copy or imitate our products or processes. We believe our intellectual
property has value, and we have taken in the past, and will take in the future, actions we deem appropriate to protect such
property from misappropriation. There can be no assurance, however, that such actions will provide meaningful protection from
competition. For additional information regarding risks related to our intellectual property, see "Risk Factors."
COMPETITION
We operate in an increasingly competitive environment within both of our product segments. Some of our competitors have
greater financial resources and more extensive design and production capabilities than we do. Certain markets in which we
operate have become more fragmented, with smaller companies entering the market. These new smaller entrants typically have
much lower levels of fixed operating overhead than we do, which enables them to be profitable with lower priced products. In
order to remain competitive with these and other companies, we must be able to continue to commit a significant portion of our
personnel, financial resources, research and development and customer support to developing new products and maintaining
customer relationships worldwide.
Our competitors include independent manufacturers, ATE manufacturers and, to a lesser extent, semiconductor manufacturers'
in-house ATE interface groups. Competitive factors in the markets we serve include price, functionality, timely product
delivery, customer service, applications support, product performance and reliability. We believe that our long-term
relationships with the industry's leading semiconductor manufacturers and other customers, and our commitment to, and
reputation for, providing high quality products, are important elements in our ability to compete effectively in all of our
markets.
- 13 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1. BUSINESS (Continued)
Our principal competitors for Thermostream(R) products are FTS Systems, a part of SP Industries, and MPI Corporation. Our
principal competitors for Thermochuck(R) products include Cascade Microtech, Inc., a subsidiary of FormFactor, Inc., ERS
Electronik GmbH and Espec Corp. Our principal competitors for environmental chambers are Cincinnati Sub-Zero Products,
Inc., Espec Corp. and Thermotron Industries. Our principal competitor for thermal platforms is Environmental Stress Systems
Inc. Our principal competitors for EKOHEAT(R) and EASYHEAT™ products are Inductotherm Corporation, Ajax-Tocco
Magneticthermic, EFD Induction Corporation, Trumpf Huettinger GmbH, and Ceia Loge.
Our principal competitors for manipulator products are Advantest Corporation, Esmo AG, Reid-Ashman Manufacturing and
Teradyne, Inc. Our principal competitors for docking hardware products include Advantest Corporation, Esmo AG, Knight
Automation, Reid-Ashman Manufacturing and Teradyne, Inc. Our principal competitors for tester interface products are
Advantest Corporation, Esmo AG, Reid-Ashman Manufacturing and Teradyne, Inc.
BACKLOG
At December 31, 2017, our backlog of unfilled orders for all products was approximately $13.7 million compared with
approximately $7.4 million at December 31, 2016. At December 31, 2017, our backlog included $5.5 million attributable to
Ambrell. Our backlog includes customer orders which we have accepted, substantially all of which we expect to deliver in
2018. While backlog is calculated on the basis of firm purchase orders, a customer may cancel an order or accelerate or
postpone currently scheduled delivery dates. Our backlog may be affected by the tendency of customers to rely on shorter lead
times available from suppliers, including us, in periods of depressed demand. In periods of increased demand, there is a
tendency towards longer lead times that has the effect of increasing backlog. As a result of these factors, our backlog at a
particular date is not necessarily indicative of sales for any future period.
EMPLOYEES
At December 31, 2017, we had 199 full time employees, including 101 in manufacturing operations, 61 in customer
support/operations and 37 in administration. Substantially all of our key employees are highly skilled and trained technical
personnel. None of our employees are represented by a labor union, and we have never experienced a work stoppage. From time
to time we retain third-party contractors to assist us in manufacturing operations and engineering and product development
projects.
ADDITIONAL INFORMATION
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and amendments to
these reports that are filed with the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act, are available free of charge
through our website (www.intest.com) as soon as reasonably practicable after we electronically file them with, or furnish them
to, the SEC. We also routinely post press releases, presentations, webcasts and other information regarding the Company on our
website. The information posted to our website is not part of this Report.
Item 1A. RISK FACTORS
The following are some of the factors that could materially and adversely affect our future performance or could cause actual
results to differ materially from those expressed or implied in our forward-looking statements. The risks and uncertainties
described below are not the only ones facing us and we cannot predict every event and circumstance that may adversely affect
our business. However, these risks and uncertainties are the most significant factors that we have identified at this time. If one
or more of these risks actually occurs, our business, results of operations and/or financial condition could suffer, and the price of
our stock could be negatively affected.
We seek to acquire additional businesses. If we are unable to do so, our future rate of growth may be reduced or limited.
We may incur significant expenses related to due diligence or other transaction-related expenses for a proposed
acquisition that may not be completed.
A key element of our growth strategy is to acquire businesses, technologies or products that are complementary to our current
product offerings. We seek to make acquisitions that will further expand our product lines as well as reduce our overall reliance
on the ATE market. We may not be able to execute our acquisition strategy if:
- 14 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1A. RISK FACTORS (Continued)
● we are unable to identify suitable businesses, technologies or products to acquire;
● we do not have sufficient cash or access to required capital at the necessary time;
● we are unwilling or unable to outbid larger, more resourceful companies; or
● we are unable to successfully close proposed acquisitions.
Our acquisition strategy involves financial and management risks which may adversely affect our results in the future.
If we acquire additional businesses, technologies or products, we will face the following additional risks:
●
future acquisitions could divert management's attention from daily operations or otherwise require additional
management, operational and financial resources;
● we might not be able to integrate future acquisitions into our business successfully or operate acquired businesses
profitably;
● we may realize substantial acquisition related expenses which would reduce our net earnings in future years; and
● our investigation of potential acquisition candidates may not reveal problems and liabilities of the companies that we
acquire.
If any of the events described above occur, our earnings could be reduced. If we issue shares of our stock or other rights to
purchase our stock in connection with any future acquisitions, we would dilute our existing stockholders' interests and our
earnings per share may decrease. If we issue debt in connection with any future acquisitions, lenders may require that we pledge
our assets to secure repayment of such debt and impose covenants on us which could, among other things, restrict our ability to
increase capital expenditures or to acquire additional businesses.
Our business is subject to intense competition, which has in the past and could in the future, materially adversely affect
our business, financial condition and results of operations.
We face significant competition throughout the world in each of our product segments. Some of our competitors have
substantial financial resources and more extensive design and production capabilities than we do. Some of our competitors are
much smaller than we are, and therefore have much lower levels of overhead than we do, which enables them to sell their
competing products at lower prices. In order to remain competitive, we must be able to continually commit a significant portion
of our personnel and financial resources to developing new products and maintaining customer satisfaction worldwide. We
expect our competitors to continue to improve the performance of their current products and introduce new products or
technologies. Over the last several years, in response to significant declines in global demand for our products, some
competitors have reduced their product pricing significantly, which has led to intensified price based competition, which has
and could continue to materially adversely affect our business, financial condition and results of operations.
Our sales are affected by the cyclicality and seasonality of the semiconductor and ATE markets, which causes our
operating results to fluctuate significantly.
Our business depends in significant part upon the capital expenditures of semiconductor manufacturers. Capital expenditures by
these companies depend upon, among other things, the current and anticipated market demand for semiconductors and the
products that utilize them. Typically, semiconductor manufacturers curtail capital expenditures during periods of economic
downturn. Conversely, semiconductor manufacturers increase capital expenditures when market demand requires the addition
of new or expanded production capabilities or the reconfiguration of existing fabrication facilities to accommodate new
products. In addition to being cyclical, the ATE market has also developed a seasonal pattern in the last several years, with the
second and third quarters being the periods of strong demand and the first and fourth quarters being periods of weakened
demand. We believe this change has been driven by the strong demand for consumer products containing semiconductor content
sold during the year-end holiday shopping season. These market changes and seasonal sales pattern have contributed in the past,
and will likely continue to contribute in the future, to fluctuations in our operating results.
We seek to further diversify the markets for our thermal products in order to increase the proportion of our sales
attributable to markets which are less subject to cyclicality than the semiconductor and ATE markets. If we are unable
to do so, our future performance will remain substantially exposed to the fluctuations of the cyclicality of the
semiconductor and ATE markets.
- 15 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1A. RISK FACTORS (Continued)
Since 2009, we have sold our thermal products in markets outside of the semiconductor market, including the automotive,
consumer electronics, defense/aerospace, energy, industrial and telecommunications markets. During 2017 and 2016, our sales
to these non-semiconductor markets were $29.0 million (including $13.2 million of net revenues attributable to Ambrell) and
$12.2 million, respectively, and represented 44% and 30% of our consolidated net revenues, respectively. Prior to our
acquisition of Ambrell, we offered only highly specialized engineering solutions in these markets outside the semiconductor
market, the demand for which is limited and which we expect may vary significantly from period to period. Our goal is to
increase our sales into these and other non-semiconductor markets; however, in most cases, the expansion of our thermal
product sales into these new markets has occurred in the last several years, and we may experience difficulty in expanding our
sales efforts further into these markets. These difficulties could include hiring sales and marketing staff with sufficient
experience selling into these new markets and our ability to continue to develop products which meet the needs of customers in
these markets and which are not currently offered by our competitors. In addition, due to the highly specialized nature of certain
of our product offerings in these non-semiconductor markets, we do not expect broad market penetration in many of these
markets. If we are unable to expand our sales in non-semiconductor markets, our net revenues and results of operations will
remain substantially dependent upon the cycles of the semiconductor and ATE markets.
Changes in the buying patterns of our customers have affected, and may continue to affect, demand for our products
and our gross and net operating margins. Such changes in patterns are difficult to predict and may not be immediately
apparent.
In addition to the cyclicality and seasonality of the semiconductor and ATE markets, demand for our products and our gross and
net operating margins have also been affected by changes in the buying patterns of our customers. We believe that in recent
years there have been a variety of changes within the ATE market, including, for example, changing product requirements,
longer time periods between new product offerings by OEMs and changes in customer buying patterns. In particular, demand
for the products sold by EMS, which are sold exclusively within the ATE market, and our operating margins in these product
segments have been affected by shifts in the competitive landscape, including (i) customers placing heightened emphasis on
shorter lead times (which places increased demands on our available engineering and production capacity increasing unit costs)
and ordering in smaller quantities (which prevents us from acquiring component materials in larger volumes at lower cost and
increasing unit costs), (ii) the increasing practice of OEMs specifying other suppliers as primary vendors, with less frequent
opportunities to compete for such designations, (iii) customers requiring products with a greater range of use at the lowest cost,
and (iv) customer supply chain management groups demanding lower prices and spreading purchases across multiple vendors.
These shifts in market practices have had, and may continue to have, varying degrees of impact on our net revenues and our
gross and net operating margins. Such shifts are difficult to predict and may not be immediately apparent, and the impact of
these practices is difficult to quantify from period to period. There can be no assurance that we will be successful in
implementing effective strategies to counter these shifts.
We generate a large portion of our sales from a small number of customers. If we were to lose one or more of our large
customers, operating results could suffer dramatically.
During the years ended December 31, 2017 and 2016, Hakuto Co. Ltd., one of our distributors, accounted for 11% and 13% of
our consolidated net revenues, respectively. These revenues were generated by our Thermal segment. During the years ended
December 31, 2017 and 2016, Texas Instruments Incorporated accounted for 11% and 10% of our consolidated net revenues,
respectively. While both of our operating segments sold products to this customer, these revenues were primarily generated by
our EMS segment. Our ten largest customers accounted for approximately 46% and 50% of our consolidated net revenues in
2017 and 2016, respectively. The loss of any one or more of our largest customers, or a reduction in orders by a major customer,
could materially reduce our net revenues or otherwise materially affect our business, financial condition or results of operations.
Our operating results often change significantly from quarter to quarter and may cause fluctuations in our stock price.
Historically, our operating results have fluctuated significantly from quarter to quarter. We believe that these fluctuations
occur primarily due to the cycles of demand in the semiconductor manufacturing industry. In addition to the changing cycles
of demand in the semiconductor manufacturing industry, other factors that have caused our quarterly operating results to
fluctuate in the past, and that may cause fluctuations and losses in the future, include:
- 16 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1A. RISK FACTORS (Continued)
● contingent consideration liability adjustments;
●
changes in demand in the markets we serve outside the ATE market including the automotive, consumer electronics,
defense/aerospace, energy, industrial and telecommunication markets;
the state of the U.S. and global economies;
changes in the buying patterns of our customers;
changes in our market share;
the technological obsolescence of our inventories;
fluctuations in the level of product warranty charges;
competitive pricing pressures;
costs related to due diligence and transaction-related expenses for a proposed acquisition that does not get completed;
costs and timing of integration of our acquisitions and plant consolidations and relocations;
excess manufacturing capacity;
●
●
●
●
● quantities of our inventories greater than is reasonably likely to be utilized in future periods;
●
●
●
●
●
● our ability to control operating costs;
● delays in shipments of our products;
the mix of our products sold;
●
the mix of customers and geographic regions where we sell our products;
●
changes in the level of our fixed costs;
●
●
costs associated with the development of our proprietary technology;
● our ability to obtain raw materials or fabricated parts when needed;
●
●
●
● political or economic instability.
increases in costs of component materials;
cancellation or rescheduling of orders by our customers;
changes in government regulations; and
Because the market price of our common stock has tended to vary based on, and in relation to, changes in our operating
results, fluctuations in the market price of our stock are likely to continue as variations in our quarterly results continue.
In connection with our acquisition of Ambrell in May 2017, we agreed to contingent consideration in the form of
earnouts based on the future adjusted EBITDA of Ambrell for 2017 and 2018. Significant variation in the amount of
the estimated fair value of contingent consideration from period to period is possible which could have a materially
adverse effect on our results of operations.
The consideration paid for the acquisition of Ambrell, which we acquired in May 2017, includes contingent consideration in
the form of earnouts based on the future adjusted EBITDA of Ambrell. Adjusted EBITDA is earnings (or loss) from
operations before interest expense, benefit or provision for income taxes, depreciation and amortization, and excludes other
non-recurring income and expense items as defined in the stock purchase agreement for Ambrell. The first earnout, to be paid
after calendar year 2017 is completed, is an amount equal to 8x Ambrell's adjusted EBITDA for 2017 minus the $22 million
paid at closing. At December 31, 2017, we had accrued $5.4 million as the 2017 earnout payable on our balance sheet
representing the amount of the first earnout. The second earnout, if any, to be paid after calendar year 2018 is completed, will
be an amount equal to 8x Ambrell's adjusted EBITDA for 2018 minus the sum of the $22 million paid at closing and the
earnout paid with respect to 2017. The 2017 and 2018 earnouts, in the aggregate, are capped at $18 million. To estimate the
fair value of the contingent consideration at the acquisition date, an option based income approach using a Monte Carlo
simulation model was utilized due to the non-linear payout structure. This resulted in an estimated fair value of $4.1 million,
which was recorded as a contingent consideration liability as of the acquisition date. At December 31, 2017, the estimated fair
value of our contingent consideration liability had increased to $11.1 million, and, accordingly, during the second half of
2017, we recorded a $7.0 million increase in the amounts accrued for contingent consideration. We use this same option based
income approach to estimate the fair value of the contingent consideration as of the end of each quarter. Significant variation
in the amount of the estimated fair value of contingent consideration from period to period is possible as the fair value is
affected by our then current estimation of future events including future net revenues and other items that affect future
projected adjusted EBITDA. Such variation could have a materially adverse effect on our results of operations.
- 17 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1A. RISK FACTORS (Continued)
A breach of our operational or security systems could negatively affect our business and results of operations.
We rely on various information technology networks and systems, some of which are managed by third parties, to process,
transmit and store electronic information, including confidential data, and to carry out and support a variety of business
activities, including manufacturing, research and development, supply chain management, sales and accounting. A failure in or
a breach of our operational or security systems or infrastructure, or those of our suppliers and other service providers, including
as a result of cyberattacks, could disrupt our business, result in the disclosure or misuse of proprietary or confidential
information, damage our reputation, cause losses and significantly increase our costs. In addition, domestic and international
regulatory agencies have implemented, and are continuing to implement, various reporting and remediation requirements that
companies must comply with upon learning of a breach. While we have insurance that may protect us from incurring some of
these costs, there is no assurance that such insurance coverage is adequate to cover all costs and damages incurred in connection
with a cyberattack.
Our industry is subject to rapid technological change, and our business prospects would be negatively affected if we are
unable to quickly and effectively respond to innovation in the semiconductor and ATE markets.
Semiconductor technology continues to become more complex as manufacturers incorporate ICs into an increasing variety of
products. This trend, and the changes needed in automated testing systems to respond to developments in the semiconductor
market, are likely to continue. We cannot be certain that we will be successful or timely in developing, manufacturing or selling
products that will satisfy customer needs or that will attain market acceptance. Our failure to provide products that effectively
and timely meet customer needs or gain market acceptance will negatively affect our business prospects.
If our suppliers do not meet product or delivery requirements, we could have reduced revenues and earnings.
Certain components may be in short supply from time to time because of high demand or the inability of some vendors to
consistently meet our quality or delivery requirements. A significant portion of our material purchases require some custom
work and there are not always multiple suppliers capable of performing such custom work on a timely or cost effective basis. If
any of our suppliers were to cancel commitments or fail to meet quality or delivery requirements needed to satisfy customer
orders for our products, we could lose time-sensitive customer orders, have reduced revenues and earnings, and be subject to
contractual penalties, any of which could have a material adverse effect on our business, results of operations and financial
condition.
Our business may suffer if we are unable to attract and retain key employees.
The loss of key personnel could adversely affect our ability to manage our business effectively. Our future success will depend
largely upon the continued services of our senior management and other key employees or the development of successors with
commensurate skills and talents. In the past, during periods of weakened demand which has caused us to experience operating
losses, we have implemented temporary salary and benefit reductions and eliminations that have remained in place until our
operations returned to profitability. If global economic conditions were to deteriorate and we were to implement such salary and
benefit reductions or eliminations again, or if we cannot continue to increase employee salaries and maintain employee benefits
commensurate with competitive opportunities, we may not be able to retain our senior management and other key employees.
Our business could suffer if we were to lose one of more of our senior officers or other key employees.
A substantial portion of our customers are located outside the U.S., which exposes us to foreign political and economic
risks.
We have operated internationally for many years and expect to expand our international operations as necessary to continue
expansion of our sales and service to our non-U.S. customers. Our foreign subsidiaries generated 17% and 16% of consolidated
net revenues in 2017 and 2016, respectively. Net revenues from foreign customers totaled $46.6 million, or 70% of consolidated
net revenues in 2016, and $27.2 million, or 68% of consolidated net revenues in 2016. We expect our net revenues from foreign
customers will continue to represent a significant portion of total net revenues. However, in addition to the risks generally
associated with sales and operations in the U.S., sales to customers outside the U.S. and operations in foreign countries are
subject to additional risks, which may, in the future, affect our operations. These risks include:
- 18 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 1A. RISK FACTORS (Continued)
● political and economic instability in foreign countries;
●
●
●
the imposition of financial and operational controls and regulatory restrictions by foreign governments;
the need to comply with a wide variety of U.S. and foreign import and export laws;
local business and cultural factors that differ from our normal standards and practices, including business practices that
we are prohibited from engaging in by the Foreign Corrupt Practices Act and other anti-corruption laws and
regulations;
trade restrictions;
changes in tariffs and taxes;
longer payment cycles;
fluctuations in currency exchange rates; and
the greater difficulty of administering business abroad.
●
●
●
●
●
A significant portion of our cash position is maintained overseas and we may not be able to repatriate cash from
overseas which could have an adverse effect on our financial condition.
While much of our cash is in the U.S., a significant portion is generated from and maintained by our foreign operations. As of
December 31, 2017, $2.5 million of our cash and cash equivalents was held by our foreign subsidiaries. Our financial
condition and results of operations could be adversely impacted if we are unable to maintain a sufficient level of cash flow in
the U.S. to address our cash requirements or we are unable to efficiently and timely repatriate cash from overseas. Any
payment of distributions, loans or advances to us by our foreign subsidiaries could be subject to restrictions on, or taxation of,
dividends or repatriation of earnings under applicable local law, monetary transfer restrictions and foreign currency exchange
regulations in the jurisdictions in which our subsidiaries operate. If we are unable to repatriate the earnings of our subsidiaries
it could have an adverse impact on our ability to redeploy earnings in other jurisdictions where they could be used more
profitably.
We have experienced and may continue to experience significant variability in our effective tax rates and may have
exposure to additional tax liabilities and costs.
We are subject to paying income taxes in the U.S. and various other countries in which we operate. Our effective tax rate is
dependent on where our earnings are generated and the tax regulations and the interpretation and judgment of administrative
tax or revenue entities in the U.S. and other countries. We are also subject to tax audits in the countries where we operate. Any
material assessment resulting from an audit from an administrative tax or revenue entity could negatively affect our financial
results.
Claims of intellectual property infringement by or against us could seriously harm our businesses.
From time to time, we may be forced to respond to or prosecute intellectual property infringement claims to defend or protect
our rights or a customer's rights. These claims, regardless of merit, may consume valuable management time, result in costly
litigation or cause product shipment delays. Any of these factors could seriously harm our business and operating results. We
may have to enter into royalty or licensing agreements with third parties who claim infringement. These royalty or licensing
agreements, if available, may be costly to us. If we are unable to enter into royalty or licensing agreements with satisfactory
terms, our business could suffer. In instances where we have had reason to believe that we may be infringing the patent rights
of others, or that someone may be infringing our patent rights, we have asked our patent counsel to evaluate the validity of the
patents in question, as well as the potentially infringing conduct. If we become involved in a dispute, neither the third parties
nor the courts are bound by our counsel's conclusions.
Item 1B. UNRESOLVED STAFF COMMENTS
None.
- 19 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 2. PROPERTIES
At December 31, 2017, we leased 9 facilities worldwide. The following chart provides information regarding each of our
principal facilities that we leased at December 31, 2017:
Location
Mansfield, MA
Mt. Laurel, NJ
Fremont, CA
Scottsville, NY
Rochester, NY
Lease
Expiration
August 2021
April 2021
October 2020
April 2018
April 2028
Principal Uses
Thermal segment operations.
Approx.
Square
Footage
52,700
54,897 Corporate headquarters and EMS segment operations.
15,746
54,869
79,150
EMS segment operations.
Thermal segment operations (current principal facility for Ambrell)
Thermal segment operations (principal facility for Ambrell to be occupied
May 2018)
All of our facilities have space to accommodate our needs for the foreseeable future.
Item 3. LEGAL PROCEEDINGS
From time to time we may be a party to legal proceedings occurring in the ordinary course of business. We are not currently
involved in any material legal proceedings.
Item 4. MINE SAFETY DISCLOSURES
Not applicable.
* * * * * * * * * * * * * * * * * * * * * * * *
PART II
Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES
Market for Common Stock
Our common stock is traded on NYSE American LLC (“NYSE American”) under the symbol "INTT." The following table
sets forth the high and low sale prices of our common stock, as reported on the NYSE American for the periods indicated.
Sale prices have been rounded to the nearest full cent.
2017
First Quarter ............................................................................................. $ 6.85 $ 4.30
8.95 5.96
Second Quarter .........................................................................................
Third Quarter ............................................................................................
9.50 6.40
Fourth Quarter .......................................................................................... 10.25 7.70
Sales Price
High Low
2016
First Quarter ............................................................................................. $ 4.69 $ 3.43
4.28 3.48
Second Quarter .........................................................................................
4.15 3.65
Third Quarter ............................................................................................
4.75 3.74
Fourth Quarter ..........................................................................................
- 20 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES (Continued)
On March 16, 2018, the closing price for our common stock as reported on the NYSE American was $8.35. As of March 16,
2018, we had 10,473,558 shares outstanding that were held by approximately 1,000 beneficial and record holders.
No dividends were paid on our common stock in the years ended December 31, 2017 or 2016. We do not currently plan to pay
cash dividends in the foreseeable future. Our current policy is to use any future earnings for reinvestment in the operation and
expansion of our business, including possible acquisitions of other businesses, technologies or products. Payment of any future
dividends will be at the discretion of our Board of Directors.
Purchases of Equity Securities
There were no shares of our common stock repurchased by us or on our behalf during the quarter ended December 31, 2017.
On October 27, 2015, our Board of Directors authorized the repurchase of up to $5.0 million of our common stock from time to
time on the open market, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, or in privately negotiated
transactions (the "2015 Repurchase Plan"). Repurchases may also be made under trading plans entered into with RW Baird &
Co. (each a "10b5-1 Plan"), which permit shares to be repurchased when we might otherwise be precluded from doing so under
insider trading laws. The 2015 Repurchase Plan does not obligate us to repurchase any particular amount of common stock and
may be suspended or discontinued at any time without prior notice. The 2015 Repurchase Plan is funded using our operating
cash flow or available cash. The timing, price and amount of any shares repurchased under the 2015 Repurchase Plan is
determined by our management, based on our evaluation of market conditions and other factors. To date, all purchases have
been made in accordance with 10b5-1 Plans which provided for purchases to be made so long as the price did not exceed a
maximum price. Recently, the price of our shares has exceeded the cap. Management is considering new parameters for future
purchases and may enter into a new 10b5-1 Plan at some point under those new parameters. As of December 31, 2017, all of the
Company’s 10b5-1 Plans had expired.
During 2017 and 2016, we repurchased 13,883 and 241,805 shares under the 2015 Repurchase Plan, respectively at a cost of
$62,000 and $978,000, respectively. As of December 31, 2017, we had repurchased a total of 297,020 shares at a cost of $1.2
million under the 2015 Repurchase Plan. All of the repurchased shares were retired.
Item 6. SELECTED FINANCIAL DATA
The following table contains certain selected consolidated financial data of inTEST and is qualified by the more detailed
Consolidated Financial Statements and Notes thereto included elsewhere in this Annual Report on Form 10-K and should be
read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the
other financial information included in this Annual Report on Form 10-K.
Years Ended December 31,
2014
2015
2016
2017
2013
(in thousands, except per share data)
Condensed Consolidated Statement of Operations Data:
Net revenues .............................................................................. $ 66,801 $ 40,227 $ 38,889 $ 41,796 $ 39,426
Gross margin .............................................................................. 34,690 20,378 18,698 20,462 19,015
3,962
Operating income .......................................................................
Net earnings ...............................................................................
3,077
Net earnings per common share:
2,562
1,861
4,916
3,439
4,146
2,658
3,611
975
Basic ....................................................................................... $
Diluted .................................................................................... $
0.09 $
0.09 $
0.26 $
0.26 $
0.18 $
0.18 $
0.33 $
0.33 $
0.30
0.30
Weighted average common shares outstanding:
Basic ....................................................................................... 10,285 10,314 10,473 10,432 10,364
Diluted .................................................................................... 10,339 10,333 10,494 10,466 10,419
- 21 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 6. SELECTED FINANCIAL DATA (Continued)
As of December 31,
2017
2016
2015
(in thousands)
2014
2013
Condensed Consolidated Balance Sheet Data:
Cash and cash equivalents ......................................................... $ 13,290 $ 28,611 $ 25,710 $ 23,126 $ 19,018
Working capital ......................................................................... 16,580 32,950 30,205 28,032 24,048
Total assets ................................................................................ 62,493 42,844 39,984 38,738 35,481
-
Long-term obligations ...............................................................
Total stockholders' equity .......................................................... 39,288 37,788 35,925 34,368 31,149
8,786
-
-
-
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
Overview
This MD&A should be read in conjunction with the accompanying consolidated financial statements.
Our business and results of operations are substantially dependent upon the demand for ATE by semiconductor manufacturers
and companies that specialize in the testing of ICs. As further discussed below, on May 24, 2017, we acquired Ambrell, which
sells its products almost exclusively to customers in the industrial market, which is a non-semiconductor market. We expect
that the acquisition of Ambrell will significantly reduce our dependence on customers in the semiconductor market. We
expect that our future orders and net revenues will be approximately equally split between the semiconductor and non-
semiconductor markets. Demand for ATE is driven by semiconductor manufacturers that are opening new, or expanding
existing, semiconductor fabrication facilities or upgrading equipment, which in turn is dependent upon the current and
anticipated market demand for semiconductors and products incorporating semiconductors. Such market demand can be the
result of market expansion, development of new technologies or redesigned products to incorporate new features, or the
replacement of aging equipment. In addition, we continue to focus on design improvements and new approaches for our own
products which contribute to our net revenues as our customers adopt these new products.
In the past, the semiconductor market has been highly cyclical with recurring periods of oversupply, which often have a
severe impact on the semiconductor market's demand for ATE, including the products we manufacture. This can cause wide
fluctuations in both our orders and net revenues and, depending on our ability to react quickly to these shifts in demand, can
significantly impact our results of operations. Semiconductor and ATE market cycles are difficult to predict and in recent
years have become more volatile and, in certain cases, shorter in duration. Because the market cycles are generally
characterized by sequential periods of growth or declines in orders and net revenues during each cycle, year over year
comparisons of operating results may not always be as meaningful as comparisons of periods at similar points in either up or
down cycles. In addition, during both downward and upward cycles in our industry, in any given quarter, the trend in both our
orders and net revenues can be erratic. This can occur, for example, when orders are canceled or currently scheduled delivery
dates are accelerated or postponed by a significant customer or when customer forecasts and general business conditions
fluctuate during a quarter.
In addition to being cyclical, the ATE market has also developed a seasonal pattern in the last several years, with the second
and third quarters being the periods of strong demand and the first and fourth quarters being periods of weakened demand. We
believe this change has been driven by the strong demand for consumer products containing semiconductor content sold
during the year-end holiday shopping season.
Third-party market share statistics are not available for the products we manufacture and sell into the ATE market; therefore,
comparisons of period over period changes in our market share are not easily determined. As a result, it is difficult to ascertain
if ATE market volatility in any period is the result of macro-economic or customer-specific factors impacting ATE market
demand, or if we have gained or lost market share to a competitor during the period.
- 22 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
As part of our ongoing strategy to reduce the impact of semiconductor and ATE market volatility on our business operations,
we continue to diversify our served markets to address the thermal test requirements of several other markets outside the
semiconductor market. These include the automotive, consumer electronics, consumer product packaging, defense/aerospace,
energy, fiber optics, industrial, telecommunications and other markets. We believe that these markets usually are less cyclical
than the semiconductor and ATE markets. While market share statistics exist for some of the markets we serve outside the
semiconductor market, due to the nature of our highly specialized product offerings in these non-semiconductor markets, we
do not expect broad market penetration in many of these markets and, therefore, do not anticipate developing meaningful
market shares in these non-semiconductor markets. In addition, our orders and net revenues in any given period in these
markets do not necessarily reflect the overall trends in these non-semiconductor markets due to our limited market shares.
Consequently, we are continuing to evaluate buying patterns and opportunities for growth in these non-semiconductor markets
that may affect our performance. The level of our orders and net revenues from these non-semiconductor markets has varied
in the past, and we expect will vary significantly in the future, as we work to build our presence in these markets and establish
new markets for our products. As previously mentioned, Ambrell, which we acquired in May 2017, sells its products almost
exclusively to customers in the industrial market, which is one of the non-semiconductor markets we serve. We expect that the
acquisition of Ambrell will significantly increase our orders and net revenues from markets outside the semiconductor market.
As a result, we expect that our future orders and net revenues will be approximately equally split between the semiconductor
and non-semiconductor markets.
While the majority of our orders and net revenues are derived from the ATE market, our operating results do not always
follow the overall trend in the ATE market in any given period. We believe that these anomalies may be driven by a variety of
factors within the ATE market, including, for example, changing product requirements, longer time periods between new
product offerings by OEMs and changes in customer buying patterns. In particular, demand for the products sold by EMS,
which are sold exclusively within the ATE market, and our operating margins in these product segments have been affected
by shifts in the competitive landscape, including (i) customers placing heightened emphasis on shorter lead times (which
places increased demands on our available engineering and production capacity increasing unit costs) and ordering in smaller
quantities (which prevents us from acquiring component materials in larger volumes at lower cost and increasing unit costs),
(ii) the practice of OEMs specifying other suppliers as primary vendors, with less frequent opportunities to compete for such
designations, (iii) the in-house manufacturing activities of OEMs building certain products we have historically sold to them,
including manipulators, docking hardware and tester interfaces, which has had the impact of significantly reducing the size of
the available market for those certain products, (iv) the role of third-party test and assembly houses in the ATE market and
their requirement of products with a greater range of use at the lowest cost, (v) customer supply chain management groups
demanding lower prices and spreading purchases across multiple vendors, and (vi) certain competitors aggressively reducing
their products' sales prices (causing us to either reduce our products' sales prices to be successful in obtaining the sale or
causing loss of the sale).
In addition, in recent periods we have seen instances where demand for ATE is not consistent for each of our product
segments or for any given product within a particular product segment. This inconsistency in demand for ATE can be driven
by a number of factors, but in most cases, we have found that the primary reason is unique customer-specific changes in
demand for certain products driven by the needs of their customers or markets served. These shifts in market practices and
customer-specific needs have had, and may continue to have, varying levels of impact on our operating results and are
difficult to quantify or predict from period to period. Management has taken, and will continue to take, such actions it deems
appropriate to adjust our strategies, products and operations to counter such shifts in market practices as they become evident.
Acquisition
On May 24, 2017, we completed the acquisition of Ambrell by acquiring all of its outstanding capital stock. Ambrell is a
manufacturer of precision induction heating systems used to conduct fast, efficient, repeatable non-contact heating of metals
or other electrically conductive materials, in order to transform raw materials into finished parts. The Ambrell acquisition
complements our current thermal technologies and broadens our diverse customer base, allowing expansion within many non-
semiconductor related markets, such as consumer product packaging, fiber-optics, automotive and other markets. This
acquisition has been accounted for as a business combination using purchase accounting. The purchase price for Ambrell was
$22.6 million in cash. Additional consideration in the form of earnouts may be paid based upon a multiple of adjusted
EBITDA for 2017 and 2018. The 2017 and 2018 earnouts, in the aggregate, are capped at $18 million. As of December 31,
2017, we had accrued $5.4 million in 2017 earnout payable based on Ambrell’s 2017 adjusted EBITDA and $5.7 million as a
contingent consideration liability based on our current projections for Ambrell’s 2018 adjusted EBITDA. For further
discussion of the acquisition, see Notes 3 and 4 to our consolidated financial statements.
- 23 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
Orders and Backlog
The following table sets forth, for the periods indicated, a breakdown of the orders received by product segment and market
(in thousands).
Years Ended
December 31,
2017
2016
Change
$
%
Orders:
Thermal ...................................................................... $ 43,953 $ 27,287 $ 16,666 61 %
7,073 39 %
EMS ........................................................................... 25,058 17,985
$ 69,011 $ 45,272 $ 23,739 52 %
Semiconductor market ............................................... $ 39,214 $ 31,491 $
7,723 25 %
Non-semiconductor market ........................................ 29,797 13,781 16,016 116 %
$ 69,011 $ 45,272 $ 23,739 52 %
Total consolidated orders for the year ended December 31, 2017 were $69.0 million compared to $45.3 million for the same
period in 2016. During the year ended December 31, 2017, we recorded $14.9 million in orders attributable to Ambrell, of
which $13.8 million were attributable to the industrial market, which is a non-semiconductor market. When adjusted to
eliminate the impact of orders attributable to Ambrell, our consolidated orders for the year ended December 31, 2017 would
have been $54.1 million and would have increased $8.8 million, or 20%, as compared to the same period in 2016. The
increase reflects both strengthening in demand within the ATE market as well increased demand from customers in the
telecommunications and defense/aerospace markets. The higher level of demand within the ATE market is being driven, in
part, by the increasing number of ICs utilized in the automotive industry and the need to test those ICs. In addition, demand
for ATE is also being driven by products which enable the Internet of Things (IoT) and the increasing number of ICs in
consumer electronics and industrial applications.
When adjusted to eliminate the orders attributable to Ambrell, orders from customers in non-semiconductor markets for the
year ended December 31, 2017 were $16.0 million, or 30% of total consolidated orders, compared to $13.8 million, or 30% of
total consolidated orders for the same period in 2016. As previously mentioned, the increase in demand was primarily from
customers in the telecommunications and, to a lesser extent, defense/aerospace markets. The level of our orders in these non-
semiconductor markets has varied in the past, and we expect it will vary significantly in the future as we build our presence in
these markets and establish new markets for our products.
At December 31, 2017, our backlog of unfilled orders for all products was approximately $13.7 million compared with
approximately $7.4 million at December 31, 2016. At December 31, 2017, our backlog included $5.5 million attributable to
Ambrell. Our backlog includes customer orders which we have accepted, substantially all of which we expect to deliver in
2018. While backlog is calculated on the basis of firm purchase orders, a customer may cancel an order or accelerate or
postpone currently scheduled delivery dates. Our backlog may be affected by the tendency of customers to rely on short lead
times available from suppliers, including us, in periods of depressed demand. In periods of increased demand, there is a
tendency towards longer lead times that has the effect of increasing backlog. As a result, our backlog at a particular date is not
necessarily indicative of sales for any future period.
Net Revenues
The following table sets forth, for the periods indicated, a breakdown of the net revenues by product segment and market (in
thousands).
- 24 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
Years Ended
December 31,
2016
2017
Change
$
%
Net revenues:
Thermal ........................................................................ $ 42,233 $ 24,033 $ 18,200
8,374
EMS ............................................................................. 24,568 16,194
$ 66,801 $ 40,227 $ 26,574
76 %
52 %
66 %
Semiconductor market ................................................. $ 37,763 $ 28,045 $
35 %
Non-semiconductor market .......................................... 29,038 12,182 16,856 138 %
66 %
$ 66,801 $ 40,227 $ 26,574
9,718
Total consolidated net revenues for the year ended December 31, 2017 were $66.8 million compared to $40.2 million for the
same period in 2016. During the year ended December 31, 2017, we recorded $13.6 million in net revenues attributable to
Ambrell, of which $13.2 million were attributable to the industrial market, which is a non-semiconductor market. When
adjusted to eliminate the impact of the net revenues attributable to Ambrell, our net revenues for the year ended December
31, 2017, would have been $53.2 million and would have increased $13.0 million or 32% as compared to the same periods
in 2016. The increase in net revenues primarily reflects the factors previously mentioned in Orders and Backlog.
When adjusted to eliminate the net revenues attributable to Ambrell, net revenues from customers in non-semiconductor
markets for the year ended December 31, 2017 were $15.8 million, or 30% of total consolidated net revenues, compared to
$12.2 million, or 30% of total consolidated net revenues for the same period in 2016. The increase in net revenues was
primarily from customers in the telecommunications markets. The level of our net revenues in these non-semiconductor
markets has varied in the past, and we expect it will vary significantly in the future as we build our presence in these
markets and establish new markets for our products.
Product/Customer Mix
Both of our product segments each have multiple products that we design, manufacture and market to our customers. Due to
a number of factors, our products have varying levels of gross margin. The mix of products we sell in any period is
ultimately determined by our customers' needs. Therefore, the mix of products sold in any given period can change
significantly from the prior period. As a result, our consolidated gross margin can be significantly impacted in any given
period by a change in the mix of products sold in that period.
We sell most of our products to semiconductor manufacturers and third-party test and assembly houses (end user sales) and
to ATE manufacturers (OEM sales) who ultimately resell our equipment with theirs to both semiconductor manufacturers
and third-party test and assembly houses. Our Thermal segment also sells into a variety of other markets, including the
automotive, consumer electronics, defense/aerospace, energy, industrial and telecommunications markets. As a result of the
acquisition of Ambrell, we now also sell into the consumer products packaging, fiber optics and other markets within the
broader industrial market. The mix of customers during any given period will affect our gross margin due to differing sales
discounts and commissions. For the years ended December 31, 2017 and 2016, our OEM sales as a percentage of net
revenues were 9% and 6%, respectively.
OEM sales generally have a lower gross margin than end user sales, as OEM sales historically have had a more significant
discount. Our current net operating margins on most OEM sales, however, are only slightly less than margins on end user
sales because of the payment of third party sales commissions on most end user sales. We have also continued to experience
demands from our OEM customers' supply chain managers to reduce our sales prices to them. If we cannot further reduce
our manufacturing and operating costs, these pricing pressures will negatively affect our gross and operating margins.
Results of Operations
The results of operations for our two product segments are generally affected by the same factors described in the Overview
section above. Separate discussions and analyses for each product segment would be repetitive. The discussion and analysis
that follows, therefore, is presented on a consolidated basis and includes discussion of factors unique to each product
segment where significant to an understanding of that segment.
- 25 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
Year Ended December 31, 2017 Compared to Year Ended December 31, 2016
Net Revenues. Net revenues were $66.8 million for the year ended December 31, 2017 compared to $40.2 million for the same
period in 2016, an increase of $26.6 million or 66%. For the year ended December 31, 2017, our net revenues included $13.6
million of net revenues attributable to the aforementioned acquisition of Ambrell on May 24, 2017. When adjusted to
eliminate the impact of the acquisition of Ambrell, our net revenues for the year ended December 31, 2017 would have
increased $13.0 million or 32% as compared to the same period in 2016. We believe this increase reflects the factors
previously discussed in the Overview.
Gross Margin. Gross margin was 52% for the year ended December 31, 2017 compared to 51% for the same period in 2016.
Although our fixed operating costs increased $3.1 million in absolute dollar terms, they were more fully absorbed by the
higher net revenue levels, resulting in the improvement in gross margin in 2017 as compared to 2016. Of the $3.1 million
increase in the absolute dollar value of these costs, $2.3 million represents the fixed operating costs attributable to Ambrell.
The remaining $764,000 increase in our fixed operating costs primarily reflects higher salary and benefits expense for our
Thermal segment as a result of an increased use of temporary labor for operations support due to the increased order and
shipment activity. To a lesser extent, both of our segments incurred higher costs for insurance premiums related to our
employee benefit plans and an increase in our facility related costs in 2017 as compared to 2016.
Selling Expense. Selling expense was $8.1 million for the year ended December 31, 2017 compared to $5.6 million for the
same period in 2016, an increase of $2.5 million or 46%. Our expense for 2017 included $2.1 million of selling costs
attributable to Ambrell. The remaining increase of $458,000 primarily reflects higher levels of commission expense reflecting
the higher net revenues, and, to a lesser extent, an increase in salary and benefits expense for our Thermal segment.
Engineering and Product Development Expense. Engineering and product development expense was $4.3 million for the year
ended December 31, 2017 compared to $3.7 million for the same period in 2016, an increase of $641,000, or 18%. Our
expense for 2017 included $650,000 of engineering costs attributable to Ambrell. When adjusted to eliminate this amount,
engineering expense would have decreased $9,000 for 2017 as compared to same period in 2016. Decreases in spending on
legal matters related to our intellectual property and lower salary and benefits expense for our EMS product segment were
offset by increased spending on materials used in new product development, primarily for our Thermal segment.
General and Administrative Expense. General and administrative expense was $11.7 million for the year ended December 31,
2017 compared to $7.0 million for the same period in 2016, an increase of $4.7 million, or 67%. Our expense for 2017
included $935,000 of transaction costs related to the acquisition of Ambrell on May 24, 2017, and $3.0 million of general and
administrative expense attributable to Ambrell. Ambrell’s general and administrative expense included $950,000 of
amortization of intangible assets. Our expenses for 2016 included $510,000 of transaction costs related to an acquisition that
did not close. When adjusted to eliminate these items, general and administrative expense would have increased $1.4 million
or 21%, primarily reflecting an increase in accruals for profit-related bonuses, higher levels of professional fees and, to a
lesser extent, an increase in travel costs.
Contingent Consideration Liability. During the year ended December 31, 2017, we recorded an increase of $7.0 million in the
fair value of our liability for contingent consideration. This liability is a result of the aforementioned acquisition of Ambrell in
May 2017 and is discussed further in Notes 3 and 4 to our consolidated financial statements. This increase primarily reflects
higher actual adjusted EBITDA for the year ended December 31, 2017 as a result of significantly higher than expected levels
of net revenues in the fourth quarter of 2017 and an increase in the projected adjusted EBITDA for the year ended December
31, 2018, also as a result of current forecasts for net revenues in 2018 which exceed the amounts projected as of the
acquisition date.
Income Tax Expense. For the year ended December 31, 2017, we recorded income tax expense of $2.9 million compared to
$1.5 million for the same period in 2016. Our effective tax rate was 75% for 2017 compared to 37% for 2016. On a quarterly
basis, we record income tax expense or benefit based on the expected annualized effective tax rate for the various taxing
jurisdictions in which we operate our businesses. The increase in our effective tax rate for 2017 primarily reflects the
aforementioned adjustment to our liability for contingent consideration which is not deductible for tax purposes. In addition,
our effective tax rate for 2017 reflects the impact of tax legislation enacted in December 2017 which, among other things,
reduces the corporate tax rate to 21% starting in 2018 and creates a territorial tax system with a one-time mandatory transition
tax on previously deferred earnings of foreign subsidiaries.
- 26 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
Liquidity and Capital Resources
As discussed more fully in the Overview, our business and results of operations are substantially dependent upon the demand
for ATE by semiconductor manufacturers and companies that specialize in the testing of ICs. The cyclical and volatile nature
of demand for ATE makes estimates of future revenues, results of operations and net cash flows difficult.
Our primary historical source of liquidity and capital resources has been cash flow generated by our operations and we
manage our businesses to maximize operating cash flows as our primary source of liquidity. We use cash to fund growth in
our operating assets, for new product research and development, for acquisitions and for stock repurchases.
Liquidity
Our cash and cash equivalents and working capital were as follows (in thousands):
Cash and cash equivalents ............................................................... $ 13,290 $ 28,611
Working capital ............................................................................... $ 16,580 $ 32,950
December 31,
2017
2016
As of December 31, 2017, $2.5 million of our cash and cash equivalents was held by our foreign subsidiaries. We currently
expect our cash and cash equivalents and projected future cash flow to be sufficient to support our short term working capital
requirements, the post-acquisition integration of Ambrell, the 2017 earnout payable and potential contingent consideration
payments for Ambrell and other corporate requirements. However, we may need additional financial resources, which could
include debt or equity financings, to consummate a significant acquisition if the consideration in such a transaction would
require us to utilize a substantial portion of, or an amount equal to or in excess of, our available cash. We do not currently
have any credit facilities under which we can borrow to help fund our working capital or other requirements.
Cash Flows
Operating Activities. Net cash provided by operations for the year ended December 31, 2017 was $7.2 million. During 2017,
we recorded net earnings of $975,000 which included non-cash charges of $7.0 million for an increase in the fair value of our
contingent consideration liability related to the acquisition of Ambrell, $1.8 million for depreciation and amortization,
$344,000 for amortization of deferred compensation expense related to stock-based awards, and $251,000 as a provision for
excess and obsolete inventory. We also recorded a deferred income tax benefit of $1.6 million during 2017 primarily as a
result of tax legislation enacted in December 2017. Approximately $950,000 of our amortization expense was related to the
intangible assets acquired as part of the acquisition of Ambrell in May 2017, which is discussed further in the Overview and
Note 3 to our consolidated financial statements. When adjusted to eliminate the assets and liabilities purchased in the
acquisition of Ambrell, accounts receivable increased $3.0 million during 2017, reflecting the increased business activity,
while accounts payable decreased $756,000, primarily reflecting the timing of payments to vendors. During 2017, accrued
wages and benefits increased $512,000 as a result of higher levels of accruals for profit-related bonuses and domestic and
foreign income taxes payable increased $586,000 as a result of higher levels of taxable income during 2017.
Investing Activities. During 2017, we completed the acquisition of Ambrell for $22.0 million, net of cash acquired, as
discussed in further detail in the Overview and Note 3 to our consolidated financial statements. During 2017, purchases of
property and equipment were $745,000. We currently plan to spend approximately $2.1 million on leasehold improvements
for a new facility for Ambrell in Rochester, New York. We expect to spend these funds during the first half of 2018 and
expect to take occupancy on May 1, 2018. We have received grants from the State of New York and the City of Rochester for
up to $550,000 in project cost reimbursements and $350,000 in refundable tax credits. The grants are dependent upon Ambrell
maintaining and creating jobs locally during the five years following acceptance of the grants and will be provided to us once
the tenant improvements have been completed, minimum full time employment targets are met and appropriate certifications
are made. The refundable tax credits also have requirements related to maintaining and creating jobs locally for the period
from June 2019 through January 1, 2029. We have no other significant commitments for capital expenditures for 2018;
however, depending upon changes in market demand or manufacturing and sales strategies, we may make such purchases or
investments as we deem necessary and appropriate.
- 27 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
Financing Activities. During 2017, we utilized $62,000 to repurchase 13,883 shares of our common stock under the 2015
Repurchase Plan.
New or Recently Adopted Accounting Standards
See Note 2 to the consolidated financial statements for information concerning the implementation and impact of new or
recently adopted accounting standards.
Critical Accounting Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the
United States of America requires us to make estimates and judgments that affect the reported amounts of assets, liabilities,
revenues, expenses and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates,
including those related to inventories, long-lived assets, goodwill, identifiable intangibles, contingent consideration liabilities
and deferred income tax valuation allowances. We base our estimates on historical experience and on appropriate and
customary assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Some of
these accounting estimates and assumptions are particularly sensitive because of their significance to our consolidated
financial statements and because of the possibility that future events affecting them may differ markedly from what had been
assumed when the financial statements were prepared.
Inventory Valuation
Inventories are valued at cost on a first-in, first-out basis, not in excess of market value. On a quarterly basis, we review our
inventories and record excess and obsolete inventory charges based upon our established objective excess and obsolete
inventory criteria. These criteria identify material that has not been used in a work order during the prior twelve months and
the quantity of material on hand that is greater than the average annual usage of that material over the prior three years. In
certain cases, additional excess and obsolete inventory charges are recorded based upon current market conditions, anticipated
product life cycles, new product introductions and expected future use of the inventory. The excess and obsolete inventory
charges we record establish a new cost basis for the related inventories. During 2017 and 2016, we recorded inventory
obsolescence charges for excess and obsolete inventory of $251,000 and $226,000, respectively.
Goodwill, Intangible and Long-Lived Assets
We account for goodwill and intangible assets in accordance with Accounting Standards Codification ("ASC") 350
(Intangibles- Goodwill and Other). Finite-lived intangible assets are amortized over their estimated useful economic life and
are carried at cost less accumulated amortization. Goodwill is assessed for impairment at least annually in the fourth quarter,
on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill may
be impaired. As a part of the goodwill impairment assessment, we have the option to perform a qualitative assessment to
determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. If we
determine this is the case, we are required to perform a two-step goodwill impairment test to identify potential goodwill
impairment and measure the amount of goodwill impairment loss to be recognized. The two-step test is discussed below. If we
determine that it is more-likely-than-not that the fair value of the reporting unit is greater than its carrying amounts, the two-
step goodwill impairment test is not required.
If we determine it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a result of
our qualitative assessment, we will perform a quantitative two-step goodwill impairment test. In the Step I test, the fair value
of a reporting unit is computed and compared with its book value. If the book value of a reporting unit exceeds its fair value, a
Step II test is performed in which the implied fair value of goodwill is compared with the carrying amount of goodwill. If the
carrying amount of goodwill exceeds the implied fair value, an impairment loss is recorded in an amount equal to that excess.
The two-step goodwill impairment assessment is based upon a combination of the income approach, which estimates the fair
value of our reporting units based upon a discounted cash flow approach, and the market approach which estimates the fair
- 28 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
value of our reporting units based upon comparable market multiples. This fair value is then reconciled to our market
capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units
requires management to make significant estimates and assumptions including the selection of appropriate peer group
companies, control premiums, discount rate, terminal growth rates, forecasts of revenue and expense growth rates, income tax
rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning
future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting
unit or the amount of the goodwill impairment charge. As of December 31, 2017 and 2016, goodwill was $13.7 million and
$1.7 million, respectively. We did not record any impairment charges related to our goodwill during 2017 or 2016.
Indefinite-lived intangible assets are assessed for impairment at least annually in the fourth quarter, or more frequently if
events or changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have
the option to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived
intangible asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the
fair value of the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required.
Otherwise, no further testing is required. The quantitative impairment test consists of a comparison of the fair value of the
intangible asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment
loss is recognized in an amount equal to that excess. As of December 31, 2017 and 2016, our indefinite-lived intangible assets
were trademarks carried at $6.7 million and $510,000, respectively. We did not record any impairment charges related to our
indefinite-lived intangible assets during 2017 or 2016.
Long-lived assets, which consist of finite-lived intangible assets and property and equipment, are assessed for impairment
whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully
recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of
the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down
to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best
estimates using appropriate assumptions and projections at that time. At December 31, 2017 and 2016, finite-lived intangibles
and long-lived assets were $10.8 million and $1.3 million, respectively. We did not record any impairment charges related to
our long-lived assets during 2017 or 2016.
Contingent Consideration Liability
The contingent consideration liability on our balance sheet is accounted for in accordance with the guidance in ASC 820 (Fair
Value Measurement). ASC 820 establishes a fair value hierarchy for instruments measured at fair value that distinguishes
between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). Our
contingent consideration liability is measured at fair value on a recurring basis using Level 3 inputs which are inputs that are
unobservable and significant to the overall fair value measurement. These unobservable inputs reflect our assumptions about
the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information
available in the circumstances.
Our contingent consideration liability is a result of our acquisition of Ambrell on May 24, 2017, and it represents the
estimated fair value of the additional cash consideration payable that is contingent upon the achievement of certain financial
results by Ambrell in 2018, as discussed more fully in Note 3. The fair value of this Level 3 instrument involves generating
various scenarios for projected adjusted EBITDA over a specified time period, calculating the associated contingent
consideration payments and discounting the average payments to present value. During the second half of 2017, we recorded a
$7.0 million increase in the fair value of our contingent consideration liability. These increases primarily reflect higher actual
adjusted EBITDA for the year ended December 31, 2017 as a result of significantly higher than expected levels of net
revenues and EBITDA in the fourth quarter of 2017 and an increase in the projected adjusted EBITDA for the year ended
December 31, 2018, also as a result of current forecasts for net revenues in 2018 which exceed the amounts projected as of the
acquisition date. As of December 31, 2017, the contingent consideration liability on our balance sheet for the 2018 earnout
was $5.7 million.
- 29 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS (Continued)
Income Taxes
Deferred tax assets are analyzed to determine if there will be sufficient taxable income in the future in order to realize such
assets. We assess all of the positive and negative evidence concerning the realizability of the deferred tax assets, including our
historical results of operations for the recent past and our projections of future results of operations, in which we make
subjective determinations of future events. If, after assessing all of the evidence, both positive and negative, a determination is
made that the realizability of the deferred tax assets is not more likely than not, we establish a deferred tax valuation
allowance for all or a portion of the deferred tax assets depending upon the specific facts. If any of the significant assumptions
were changed, materially different results could occur, which could significantly change the amount of the deferred tax
valuation allowance established. As of December 31, 2017, we had a net deferred tax liability of $3.0 million. As of
December 31, 2016, we had a net deferred tax asset of $1.1 million. Our deferred tax valuation allowance at December 31,
2017 and 2016 was $370,000 and $0, respectively.
Off -Balance Sheet Arrangements
There were no off-balance sheet arrangements during the year ended December 31, 2017 that have or are reasonably likely to
have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of
operations, liquidity, capital expenditures or capital resources that is material to our interests.
Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
This disclosure is not required for a smaller reporting company.
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Consolidated financial statements are set forth in this Report beginning at page F-1 and are incorporated by reference into this
Item 8.
Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
None.
Item 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act. Because
there are inherent limitations in all control systems, a control system, no matter how well conceived and operated, can provide
only reasonable, as opposed to absolute, assurance that the objectives of the control system are met. These inherent limitations
include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error
or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more
people, or by management override of the control. Further, the design of a control system must reflect the fact that there are
resource constraints, and the benefits of controls must be considered relative to their costs. Our management, including the
Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), does not expect that our disclosure controls and
procedures or our internal control over financial reporting will prevent all error and all fraud. Because of the inherent
limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Accordingly,
our management has designed the disclosure controls and procedures to provide reasonable assurance that the objectives of
the control system were met.
- 30 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 9A. CONTROLS AND PROCEDURES (Continued)
CEO/CFO Conclusions about the Effectiveness of the Disclosure Controls and Procedures. As required by Rule 13a-
15(b), inTEST management, including our CEO and CFO, conducted an evaluation as of the end of the period covered by this
Report, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our CEO and CFO concluded
that, as of the end of the period covered by this Report, our disclosure controls and procedures were effective at the reasonable
assurance level.
Changes in Internal Control Over Financial Reporting
During the period covered by this Report, there has been no change in our internal control over financial reporting (as defined
in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Report that has
materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Management's Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal
control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as
amended, as a process designed by, or under the supervision of, our principal executive and principal financial officers and
effected by our Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles and includes those policies and procedures that:
1. Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions
and dispositions of our assets;
2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that our receipts and
expenditures are being made only in accordance with authorizations of our management and directors; and
3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of our assets that could have a material effect on the financial statements.
Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of
changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2017. In making
this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO) on Internal Control-Integrated 2013 Framework. Based upon this assessment, management believes
that, as of December 31, 2017, our internal control over financial reporting is effective at a reasonable assurance level.
This annual report does not include an attestation report of our independent registered public accounting firm regarding
internal control over financial reporting, as such an attestation is not required pursuant to rules of the SEC applicable to
smaller reporting companies.
Item 9B. OTHER INFORMATION
None.
- 31 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
PART III
Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this Item is incorporated by reference from our definitive proxy statement for our 2018 Annual
Meeting of Stockholders to be filed with the SEC on or before April 30, 2018, or, if our proxy statement is not filed on or
before April 30, 2018, will be filed by that date by an amendment to this Form 10-K.
Item 11. EXECUTIVE COMPENSATION
The information required by this Item is incorporated by reference from our definitive proxy statement for our 2018 Annual
Meeting of Stockholders to be filed with the SEC on or before April 30, 2018, or, if our proxy statement is not filed on or
before April 30, 2018, will be filed by that date by an amendment to this Form 10-K.
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDER MATTERS
The information required by Item 201(d) of Regulation S-K is set forth below. The remainder of the information required by
this Item 12 is incorporated by reference from our definitive proxy statement for our 2018 Annual Meeting of Stockholders to
be filed with the SEC on or before April 30, 2018, or, if our proxy statement is not filed on or before April 30, 2018, will be
filed by that date by an amendment to this Form 10-K.
The following table shows the number of securities that may be issued pursuant to our equity compensation plans (including
individual compensation arrangements) as of December 31, 2017:
Equity Compensation Plan Information
Plan Category
Equity compensation plans approved by security holders ........
Equity compensation plans not approved by security holders ..
Total ..........................................................................................
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights(1)
76,400
-
76,400
Weighted-average
exercise price of
outstanding
options,
warrants and rights
$ 5.98
-
$ 5.98
Number of securities
remaining available
for future issuance
under equity
compensation plans(2)
345,200
-
345,200
(1) The securities that may be issued are shares of inTEST common stock, issuable upon exercise of outstanding stock options.
(2) The securities that remain available for future issuance are issuable pursuant to the 2014 Stock Plan.
Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this Item is incorporated by reference from our definitive proxy statement for our 2018 Annual
Meeting of Stockholders to be filed with the SEC on or before April 30, 2018, or, if our proxy statement is not filed on or
before April 30, 2018, will be filed by that date by an amendment to this Form 10-K.
- 32 -
inTEST CORPORATION
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2017
Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required by this Item is incorporated by reference from our definitive proxy statement for our 2018 Annual
Meeting of Stockholders to be filed with the SEC on or before April 30, 2018, or, if our proxy statement is not filed on or
before April 30, 2018, will be filed by that date by an amendment to this Form 10-K.
* * * * * * * * * * * * * * * * * * * * * * * *
PART IV
Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a) The documents filed as part of this Annual Report on Form 10-K are:
(i) Our consolidated financial statements and notes thereto as well as the applicable report of our independent
registered public accounting firm are included in Part II, Item 8 of this Annual Report on Form 10-K.
(ii) The following financial statement schedule should be read in conjunction with the consolidated financial statements
set forth in Part II, Item 8 of this Annual Report on Form 10-K:
Schedule II -- Valuation and Qualifying Accounts
(iii) The exhibits required by Item 601 of Regulation S-K are included under Item 15(b) of this Annual Report on Form
10-K.
(b) Exhibits required by Item 601 of Regulation S-K:
A list of the Exhibits which are required by Item 601 of Regulation S-K and filed with this Report is set forth in the
Exhibit Index immediately preceding the signature page, which Exhibit Index is incorporated herein by reference.
Item 16. FORM 10-K SUMMARY
None.
- 33 -
Index to Exhibits (A)
Exhibit
Number Description of Exhibit
2.1
Stock Purchase Agreement among Ambrell Holdings, LLC, Ambrell Corporation, Graycliff Private Equity Partners III
LP, Hudson River Co-Investment Fund II LP and inTEST Corporation dated as of May 24, 2017 (1)
3.1
3.2
10.1
10.2
Certificate of Incorporation. (2)
Bylaws as amended on June 23, 2014. (3)
Lease Agreement between Exeter 804 East Gate, LLC and the Company dated May 10, 2010. (4)
Lease Agreement between AMB-SGP Seattle/Boston, LLC and Temptronic Corporation (a subsidiary of the Company),
dated October 25, 2010. (5)
10.3
Lease Agreement between Columbia California Warm Springs Industrial, LLC and inTEST Silicon Valley Corporation
dated January 9, 2012. (6)
10.4
First Amendment to Lease Agreement between Columbia California Warm Springs Industrial, LLC and inTEST Silicon
Valley Corporation dated November 18, 2016. (7)
10.5
Guaranty Agreements between Columbia California Warm Springs Industrial, LLC and inTEST Corporation dated
January 9, 2012. (6)
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
10.14
10.15
10.16
10.17
Lease Agreement between Maguire Family Properties, Inc. and Ambrell Corporation dated December 19, 2017 (8)
Guaranty of Lease between Maguire Family Properties, Inc. and Ambrell Corporation dated December 19, 2017 (8)
Form of Indemnification Agreement (9)(*)
inTEST Corporation 2014 Stock Plan (*)
inTEST Corporation 2007 Stock Plan. (*)
Form of Restricted Stock Award Agreement. (10)(*)
Form of Non-Qualified Stock Option Agreement. (10)(*)
Form of Incentive Stock Option Agreement. (10)(*)
Change of Control Agreement dated August 27, 2007 between the Company and Robert E. Matthiessen. (11)(*)
Change of Control Agreement dated August 27, 2007 between the Company and Hugh T. Regan, Jr. (11)(*)
Change of Control Agreement dated May 5, 2008 between the Company and James Pelrin. (12)(*)
Amendment to Change of Control Agreement dated December 31, 2008 between the Company and Robert E.
Matthiessen. (13)(*)
10.18
Amendment to Change of Control Agreement dated December 31, 2008 between the Company and Hugh T. Regan, Jr.
(13)(*)
10.19
10.20
14
21
23
31.1
31.2
32.1
32.2
Amendment to Change of Control Agreement dated December 31, 2008 between the Company and James Pelrin. (13)(*)
Compensatory Arrangements of Executive Officers and Directors. (*)(14)
Code of Ethics. (15)
Subsidiaries of the Company.
Consent of RSM US LLP.
Certification of Chief Executive Officer pursuant to Rule 13a-14(a).
Certification of Chief Financial Officer pursuant to Rule 13a-14(a).
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
XBRL Taxonomy Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
- 34 -
Index to Exhibits (A)
(Continued)
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated May 24, 2017, File No.
001-36117, filed May 24, 2017, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company's Registration Statement on Form S-1, File No. 333-26457 filed
May 2, 1997, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated June 23, 2014, File No.
001-36117, filed June 25, 2014, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated May 10, 2010, File No.
000-22529, filed May 13, 2010, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated October 27, 2010, File No.
000-22529, filed October 29, 2010, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company's Form 10-Q for the quarter ended March 31, 2012, File No.
000-22529, filed May 15, 2012, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company's Current Report on Form 8-K dated November 18, 2016, File
No. 001-36117, filed November 22, 2016, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated December 19, 2017, File
No. 001-36117, filed December 22, 2017, and incorporated herein by reference.
Previously filed by the Company as an exhibit to the Company’s Current Report on Form 8-K dated October 2, 2017, File No.
001-36117, filed October 6, 2017, and incorporated herein by reference.
(10) Previously filed by the Company as an exhibit to the Company's Form 10-Q for the quarter ended March 31, 2016, File No.
001-36117, filed May 13, 2016, and incorporated herein by reference.
(11) Previously filed by the Company as an exhibit to the Company's Form 10-K for the year ended December 31, 2007, File No.
000-22529, filed March 31, 2008, and incorporated herein by reference.
(12) Previously filed by the Company as an exhibit to the Company's Form 10-Q for the quarter ended June 30, 2008, File No. 000-
22529, filed August 14, 2008, and incorporated herein by reference.
(13) Previously filed by the Company as an exhibit to the Company's Form 10-Q for the quarter ended June 30, 2009, File No. 000-
22529, filed August 14, 2009, and incorporated herein by reference.
(14) Portions of this exhibit were previously filed on the Company's Current Report on Form 8-K dated March 12, 2018, File No.
001-36117, filed March 15, 2018, and incorporated herein by reference.
(15) Previously filed by the Company as an exhibit to the Company's Form 10-Q for the quarter ended June 30, 2016, File No. 001-
36117, filed August 12, 2016, and incorporated herein by reference.
(*)
Indicates a management contract or compensatory plan, contract or arrangement in which a director or executive officers
participate.
(A) Copies of the exhibits which were filed with the SEC are not included in this Annual Report to Stockholders but may be
obtained electronically through our website at www.intest.com or through the SEC’s website at www.sec.gov.
- 35 -
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.
inTEST Corporation
By:/s/ James Pelrin
James Pelrin
President and Chief Executive Officer
March 28, 2018
Pursuant to the requirements of Securities Exchange Act of 1934, this report has been signed below by the following persons on
behalf of the Registrant and in the capacities and on the dates indicated.
/s/ James Pelrin
James Pelrin, President,
Chief Executive Officer and Director
(Principal Executive Officer)
/s/ Hugh T. Regan, Jr.
Hugh T. Regan, Jr., Treasurer, Chief
Financial Officer and Secretary
(Principal Financial Officer)
/s/ Robert E. Matthiessen
Robert E. Matthiessen, Chairman
/s/ Steven J. Abrams
Steven J. Abrams, Esq., Director
/s/ Joseph W. Dews IV
Joseph W. Dews IV, Director
/s/ William Kraut
William Kraut, Director
March 28, 2018
March 28, 2018
March 28, 2018
March 28, 2018
March 28, 2018
March 28, 2018
- 36 -
inTEST CORPORATION
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND
FINANCIAL STATEMENT SCHEDULE
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CONSOLIDATED FINANCIAL STATEMENTS
Consolidated Balance Sheets as of December 31, 2017 and 2016
Consolidated Statements of Operations for the years ended December 31, 2017 and 2016
Consolidated Statements of Comprehensive Earnings for the years ended December 31, 2017 and 2016
Consolidated Statements of Stockholders' Equity for the years ended December 31, 2017 and 2016
Consolidated Statements of Cash Flows for the years ended December 31, 2017 and 2016
Notes to Consolidated Financial Statements
FINANCIAL STATEMENT SCHEDULE
Schedule II - Valuation and Qualifying Accounts
Page
F - 1
F - 2
F - 3
F - 4
F - 5
F -6
F - 7
F - 27
- 37 -
[This page intentionally left blank.]
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and the Board of Directors of inTEST Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of inTEST Corporation and subsidiaries (the Company) as of
December 31, 2017 and 2016, the related consolidated statements of operations, comprehensive earnings, stockholders' equity and
cash flows for the years then ended, and the related notes to the consolidated financial statements and schedule (collectively, the
financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the
Company as of December 31, 2017 and 2016, and the results of its operations and its cash flows for the years then ended, in
conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the
Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in
accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for
the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly,
we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ RSM US LLP
We have served as the Company's auditor since 2008.
Blue Bell, Pennsylvania
March 28, 2018
F - 1
inTEST CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
December 31,
2017
2016
ASSETS
Current assets:
Cash and cash equivalents ....................................................................................................................... $
Trade accounts receivable, net of allowance for doubtful accounts of $213 and $146, respectively ......
Inventories ...............................................................................................................................................
Prepaid expenses and other current assets ...............................................................................................
Total current assets ..............................................................................................................................
13,290 $
12,166
4,966
577
30,999
28,611
5,377
3,676
342
38,006
Property and equipment:
Machinery and equipment .......................................................................................................................
Leasehold improvements .........................................................................................................................
Gross property and equipment .............................................................................................................
Less: accumulated depreciation ...............................................................................................................
Net property and equipment ................................................................................................................
5,033
822
5,855
(4,314 )
1,541
Deferred tax assets ......................................................................................................................................
Goodwill .....................................................................................................................................................
Intangible assets, net ...................................................................................................................................
Restricted certificates of deposit .................................................................................................................
Other assets .................................................................................................................................................
Total assets .......................................................................................................................................... $
-
13,738
16,014
175
26
62,493 $
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable .................................................................................................................................... $
Accrued wages and benefits ....................................................................................................................
Accrued rent ............................................................................................................................................
Accrued professional fees .......................................................................................................................
Accrued sales commissions .....................................................................................................................
Customer deposits and deferred revenue .................................................................................................
Domestic and foreign income taxes payable ...........................................................................................
Earnout payable .......................................................................................................................................
Other current liabilities ............................................................................................................................
Total current liabilities .........................................................................................................................
Federal transition tax payable, net of current portion .................................................................................
Deferred tax liabilities.................................................................................................................................
Contingent consideration liability, net of current portion ...........................................................................
Total liabilities .....................................................................................................................................
2,032 $
2,781
521
717
529
886
1,199
5,355
399
14,419
436
2,606
5,744
23,205
4,383
603
4,986
(4,042 )
944
1,110
1,706
875
175
28
42,844
1,368
1,588
572
419
287
74
575
-
173
5,056
-
-
-
5,056
Commitments and Contingencies (Notes 10 and 12)
Stockholders' equity:
Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding ............
Common stock, $0.01 par value; 20,000,000 shares authorized; 10,427,435 and 10,394,018 shares
issued, respectively ..............................................................................................................................
Addtional paid-in capital .........................................................................................................................
Retained earnings ....................................................................................................................................
Accumulated other comprehensive earnings ...........................................................................................
Treasury stock, at cost; 33,077 and 33,077 shares, respectively .............................................................
Total stockholders' equity ....................................................................................................................
Total liabilities and stockholders' equity .............................................................................................. $
-
-
104
25,860
12,646
882
(204 )
39,288
62,493 $
104
25,578
11,671
639
(204 )
37,788
42,844
See accompanying Notes to Consolidated Financial Statements.
F - 2
inTEST CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
Years ended December
31,
2017
2016
Net revenues ........................................................................................................................................... $
Cost of revenues ......................................................................................................................................
Gross margin ....................................................................................................................................
66,801 $
32,111
34,690
40,227
19,849
20,378
Operating expenses:
Selling expense ....................................................................................................................................
Engineering and product development expense ..................................................................................
General and administrative expense ....................................................................................................
Adjustment to contingent consideration liability .................................................................................
Total operating expenses .................................................................................................................
8,108
4,301
11,694
6,976
31,079
Operating income ....................................................................................................................................
Other income...........................................................................................................................................
3,611
227
Earnings before income tax expense .......................................................................................................
Income tax expense .................................................................................................................................
3,838
2,863
5,567
3,660
7,005
-
16,232
4,146
61
4,207
1,549
Net earnings ............................................................................................................................................ $
975 $
2,658
Net earnings per common share – basic .................................................................................................. $
0.09 $
0.26
Weighted average common shares outstanding – basic .......................................................................... 10,284,572 10,313,747
Net earnings per common share – diluted ............................................................................................... $
0.09 $
0.26
Weighted average common shares and common share equivalents outstanding – diluted ..................... 10,339,313 10,332,920
See accompanying Notes to Consolidated Financial Statements.
F - 3
inTEST CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS
(In thousands)
Net earnings ................................................................................................................................................. $
975 $
2,658
Foreign currency translation adjustments ....................................................................................................
243
(86 )
Comprehensive earnings .............................................................................................................................. $ 1,218 $
2,572
Years Ended
December 31,
2016
2017
See accompanying Notes to Consolidated Financial Statements
F - 4
ST CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share data)
Common Stock
Additional
Paid-In
Amount Capital
Shares
Accumulated
Other
Total
Retained Comprehensive Treasury Stockholders'
Earnings
Equity
Stock
Earnings
Balance, January 1, 2016 .................. 10,549,423 $
105 $ 26,286 $
9,013 $
725 $
(204) $
35,925
Balance, December 31, 2016 ............ 10,394,018
104
25,578 11,671
639
(204)
37,788
Net earnings ......................................
Other comprehensive loss .................
Amortization of deferred
compensation related to stock-
based awards .................................
Issuance of unvested shares of
-
-
-
-
-
-
2,658
-
-
(86 )
-
-
269
-
-
-
-
restricted stock...............................
86,400
1
(1 )
Repurchase and retirement of
common stock ...............................
(241,805 )
(2 )
(976 )
-
-
-
-
-
-
975
-
-
243
Net earnings ......................................
Other comprehensive loss .................
Amortization of deferred
compensation related to stock-
based awards .................................
Issuance of unvested shares of
-
-
344
restricted stock...............................
66,000
Forfeiture of unvested shares of
restricted stock...............................
(18,700 )
Repurchase and retirement of
common stock ...............................
(13,883 )
-
-
-
-
-
(62 )
-
-
-
-
-
-
-
-
-
-
2,658
(86 )
269
-
(978 )
-
-
-
-
-
975
243
344
-
-
(62 )
Balance, December 31, 2017 ............ 10,427,435 $
104 $ 25,860 $ 12,646 $
882 $
(204) $
39,288
See accompanying Notes to Consolidated Financial Statements
F - 5
inTEST CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Years Ended
December 31,
2017
2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings.............................................................................................................................................. $
Adjustments to reconcile net earnings to net cash provided by operating activities:
975 $
2,658
Depreciation and amortization ..........................................................................................................
Adjustment to earnout payable ..........................................................................................................
Adjustment to contingent consideration liability ..............................................................................
Provision for excess and obsolete inventory .....................................................................................
Foreign exchange (gain) loss .............................................................................................................
Amortization of deferred compensation related to stock-based awards ............................................
Proceeds from sale of demonstration equipment, net of gain ............................................................
Deferred income tax (benefit) expense..............................................................................................
Changes in assets and liabilities:
Trade accounts receivable..............................................................................................................
Inventories .....................................................................................................................................
Prepaid expenses and other current assets .....................................................................................
Restricted certificates of deposit ....................................................................................................
Other assets ....................................................................................................................................
Accounts payable ...........................................................................................................................
Accrued wages and benefits ..........................................................................................................
Accrued rent ..................................................................................................................................
Accrued professional fees ..............................................................................................................
Accrued sales commissions ...........................................................................................................
Customer deposits and deferred revenue .......................................................................................
Domestic and foreign income taxes payable .................................................................................
Other current liabilities ..................................................................................................................
Federal transition tax payable ........................................................................................................
Net cash provided by operating activities ....................................................................................................
1,779
5,355
1,621
251
(146 )
344
152
(1,630 )
(2,983 )
388
(31 )
-
2
(756 )
512
(51 )
210
137
55
586
36
436
7,242
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of business, net of cash acquired ........................................................................................... (21,962 )
(745 )
Purchase of property and equipment ........................................................................................................
36
Proceeds from sale of property and equipment ........................................................................................
Net cash used in investing activities ............................................................................................................ (22,671 )
CASH FLOWS FROM FINANCING ACTIVITIES
Repurchases of common stock .................................................................................................................
Net cash used in financing activities ............................................................................................................
(62 )
(62 )
599
-
-
226
16
269
129
135
(1,009 )
(384 )
295
175
178
459
126
(85 )
57
(10 )
(118 )
549
23
-
4,288
-
(339 )
-
(339 )
(978 )
(978 )
(70 )
170
Effects of exchange rates on cash ................................................................................................................
2,901
Net cash provided by (used in) all activities ................................................................................................ (15,321 )
Cash and cash equivalents at beginning of period .......................................................................................
25,710
28,611
Cash and cash equivalents at end of period ................................................................................................. $ 13,290 $ 28,611
Cash payments for:
Domestic and foreign income taxes ......................................................................................................... $
3,467 $
635
Details of acquisition:
Fair value of assets acquired, net of cash ................................................................................................. $ 22,652
(8,599 )
Liabilities assumed ...................................................................................................................................
12,032
Goodwill resulting from acquisition .........................................................................................................
(4,123 )
Contingent consideration ..........................................................................................................................
Net cash paid for acquisition ........................................................................................................................ $ 21,962
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of unvested shares of restricted stock ........................................................................................ $
Forfeiture of unvested shares of restricted stock ......................................................................................
432 $
(104 )
369
-
See accompanying Notes to Consolidated Financial Statements.
F - 6
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(1) NATURE OF OPERATIONS
We are an independent designer, manufacturer and marketer of thermal management products and semiconductor automated
test equipment (“ATE”) interface solutions. Our products are used by semiconductor manufacturers to perform development,
qualifying and final testing of integrated circuits (“ICs”) and wafers, and for other electronic testing across a range of
industries including the automotive, defense/aerospace, energy, industrial and telecommunications markets. We also offer
induction heating products for joining and forming metals in a variety of industrial markets, including automotive, aerospace,
machinery, wire & fasteners, medical, semiconductor, food & beverage, and packaging. We manufacture our products in the
U.S. Marketing and support activities are conducted worldwide from our facilities in the U.S., Germany, Singapore, the
Netherlands and the U.K. The consolidated entity is comprised of inTEST Corporation and our wholly-owned subsidiaries.
During 2016, we reorganized our business from three product segments, Thermal Products, Mechanical Products and
Electrical Products, into two product segments, Thermal Products ("Thermal") and Electromechanical Semiconductor
Products ("EMS"). Accordingly, effective January 1, 2017, we have two reportable segments, which are also our reporting
units. Prior period information has been reclassified to be comparable to the presentation for 2017.
On May 24, 2017, we completed the acquisition of Ambrell Corporation ("Ambrell"). The acquisition was completed by
acquiring all of the outstanding capital stock of Ambrell. Ambrell is a manufacturer of precision induction heating systems
which are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials, in
order to transform raw materials into finished parts. The Ambrell acquisition complements our current thermal technologies
and broadens our diverse customer base, allowing expansion within many non-semiconductor related markets, such as
consumer product packaging, fiber-optics, automotive and other markets. Ambrell's operations are included in our Thermal
segment. Ambrell manufactures its products in the U.S. and conducts marketing and support activities from its facilities in the
U.S., the Netherlands and the U.K. This acquisition is discussed further in Note 3.
The ATE market in which we operate is characterized by rapid technological change, competitive pricing pressures and
cyclical as well as seasonal market patterns. This market is subject to significant economic downturns at various times. Our
financial results are affected by a wide variety of factors, including, but not limited to, general economic conditions worldwide
and in the markets in which we operate, economic conditions specific to the ATE market and the other markets we serve, our
ability to safeguard patented technology and intellectual property in a rapidly evolving market, downward pricing pressures
from customers, and our reliance on a relatively few number of customers for a significant portion of our sales. In addition, we
are exposed to the risk of obsolescence of our inventory depending on the mix of future business and technological changes
within the markets that we serve. We also continue to implement an acquisition strategy that may cause us to incur substantial
expense in reviewing and evaluating potential transactions. We may or may not be successful in locating suitable businesses to
acquire. In addition, we may not be able to successfully integrate any business we do acquire with our existing business and
we may not be able to operate the acquired business profitably. As a result of these or other factors, we may experience
significant period-to-period fluctuations in future operating results.
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Use of Estimates
The accompanying consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All
significant intercompany accounts and transactions have been eliminated upon consolidation. The preparation of financial
statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP")
requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates. Certain of our accounts, including inventories,
long-lived assets, goodwill, identifiable intangibles, contingent consideration and deferred tax assets and liabilities including
related valuation allowances, are particularly impacted by estimates.
Reclassification
Certain prior year amounts have been reclassified to be comparable with the current year's presentation.
F - 7
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Cash and Cash Equivalents
Short-term investments that have maturities of three months or less when purchased are considered to be cash equivalents and
are carried at cost, which approximates market value. Our cash balances, which are deposited with highly reputable financial
institutions, at times may exceed the federally insured limits. We have not experienced any losses related to these cash
balances and believe the credit risk to be minimal.
Trade Accounts Receivable and Allowance for Doubtful Accounts
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. We grant credit to customers and
generally require no collateral. To minimize our risk, we perform ongoing credit evaluations of our customers' financial
condition. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing
accounts receivable. We determine the allowance based on historical write-off experience and the aging of such receivables,
among other factors. Account balances are charged off against the allowance after all means of collection have been exhausted
and the potential for recovery is considered remote. We do not have any off-balance sheet credit exposure related to our
customers. We recorded bad debt expense of $68 for the year ended December 31, 2017. There was no bad debt expense
recorded for the year ended December 31, 2016. Cash flows from accounts receivable are recorded in operating cash flows.
Fair Value of Financial Instruments
Our financial instruments include accounts receivable, accounts payable and our liability for contingent consideration. Our
accounts receivable and accounts payable are carried at cost which approximates fair value, due to the short maturities of the
accounts. Our liability for contingent consideration is accounted for in accordance with the guidance in Accounting Standards
Codification ("ASC") 820 (Fair Value Measurement). ASC 820 establishes a fair value hierarchy for instruments measured at
fair value that distinguishes between assumptions based on market data (observable inputs) and our own assumptions
(unobservable inputs). Our contingent consideration liability is measured at fair value on a recurring basis using Level 3 inputs
which are inputs that are unobservable and significant to the overall fair value measurement. These unobservable inputs reflect
our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based
on the best information available in the circumstances. See Note 4 for further disclosures related to the fair value of our
liability for contingent consideration.
Inventories
Inventories are valued at cost on a first-in, first-out basis, not in excess of market value. Cash flows from the sale of
inventories are recorded in operating cash flows. On a quarterly basis, we review our inventories and record excess and
obsolete inventory charges based upon our established objective excess and obsolete inventory criteria. These criteria identify
material that has not been used in a work order during the prior twelve months and the quantity of material on hand that is
greater than the average annual usage of that material over the prior three years. In certain cases, additional excess and
obsolete inventory charges are recorded based upon current market conditions, anticipated product life cycles, new product
introductions and expected future use of the inventory. The excess and obsolete inventory charges we record establish a new
cost basis for the related inventories. We incurred excess and obsolete inventory charges of $251 and $226 for the years ended
December 31, 2017 and 2016, respectively.
Property and Equipment
Machinery and equipment are stated at cost, except for machinery and equipment acquired in a business combination, which
are stated at fair value at the time of acquisition. As further discussed below under "Goodwill, Intangible and Long-Lived
Assets," machinery and equipment that has been determined to be impaired is written down to its fair value at the time of the
impairment. Depreciation is based upon the estimated useful life of the assets using the straight-line method. The estimated
useful lives range from one to ten years. Leasehold improvements are recorded at cost and amortized over the shorter of the
lease term or the estimated useful life of the asset. Total depreciation expense was $618 and $370 for the years ended
December 31, 2017 and 2016, respectively.
F - 8
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Goodwill, Intangible and Long-Lived Assets
We account for goodwill and intangible assets in accordance with ASC 350 (Intangibles - Goodwill and Other). Finite-lived
intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization.
Goodwill is assessed for impairment annually in the fourth quarter on a reporting unit basis, or more frequently when events
and circumstances occur indicating that the recorded goodwill may be impaired. As a part of the goodwill impairment
assessment, we have the option to perform a qualitative assessment to determine whether it is more-likely-than-not that the fair
value of a reporting unit is less than its carrying amount. If we determine this is the case, we are required to perform a two-step
goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be
recognized. The two-step test is discussed below. If we determine that it is more-likely-than-not that the fair value of the
reporting unit is greater than its carrying amounts, the two-step goodwill impairment test is not required.
If we determine it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a result of
our qualitative assessment, we will perform a quantitative two-step goodwill impairment test. In the Step I test, the fair value
of a reporting unit is computed and compared with its book value. If the book value of a reporting unit exceeds its fair value, a
Step II test is performed in which the implied fair value of goodwill is compared with the carrying amount of goodwill. If the
carrying amount of goodwill exceeds the implied fair value, an impairment loss is recorded in an amount equal to that excess.
The two-step goodwill impairment assessment is based upon a combination of the income approach, which estimates the fair
value of our reporting units based upon a discounted cash flow approach, and the market approach which estimates the fair
value of our reporting units based upon comparable market multiples. This fair value is then reconciled to our market
capitalization at year end with an appropriate control premium. The determination of the fair value of our reporting units
requires management to make significant estimates and assumptions including the selection of appropriate peer group
companies, control premiums, discount rate, terminal growth rates, forecasts of revenue and expense growth rates, income tax
rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning
future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting
unit or the amount of the goodwill impairment charge.
Indefinite-lived intangible assets are assessed for impairment annually in the fourth quarter, or more frequently if events or
changes in circumstances indicate that the asset might be impaired. As a part of the impairment assessment, we have the
option to perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible
asset is impaired. If, as a result of our qualitative assessment, we determine that it is more-likely-than-not that the fair value of
the indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required. Otherwise, no
further testing is required. The quantitative impairment test consists of a comparison of the fair value of the intangible asset
with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized
in an amount equal to that excess.
Long-lived assets, which consist of finite-lived intangible assets and property and equipment, are assessed for impairment
whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully
recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of
the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down
to its estimated fair value. The cash flow estimates used to determine the impairment, if any, contain management's best
estimates using appropriate assumptions and projections at that time.
Stock-Based Compensation
We account for stock-based compensation in accordance with ASC Topic 718 (Compensation - Stock Compensation) which
requires that employee share-based equity awards be accounted for under the fair value method and requires the use of an
option pricing model for estimating fair value, which is then amortized to expense over the service periods. See further
disclosures related to our stock-based compensation plans in Note 13.
Subsequent Events
We have made an assessment of our operations and determined that there were no material subsequent events requiring
adjustment to, or disclosure in, our consolidated financial statements for the year ended December 31, 2017.
F - 9
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Revenue Recognition
We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been
rendered, the price is fixed or determinable, and collection of the related receivable is reasonably assured. Sales of our
products are made through our sales employees, third-party sales representatives and distributors. There are no differences in
revenue recognition policies based on the sales channel. We do not provide our customers with rights of return or exchanges.
Revenue is generally recognized upon product shipment. Our customers' purchase orders do not typically contain any
customer-specific acceptance criteria, other than that the product performs within the agreed upon specifications. We test all
products manufactured as part of our quality assurance process to determine that they comply with specifications prior to
shipment to a customer. To the extent that any customer purchase order contains customer-specific acceptance criteria,
revenue recognition is deferred until customer acceptance.
In addition, in our Thermal segment, we lease certain of our equipment to customers under non-cancellable operating leases.
These leases generally have an initial term of six months. We recognize revenue for these leases on a straight-line basis over
the term of the lease.
With respect to sales tax collected from customers and remitted to governmental authorities, we use a net presentation in our
consolidated statement of operations. As a result, there are no amounts included in either our net revenues or cost of revenues
related to sales tax.
Product Warranties
We generally provide product warranties and record estimated warranty expense at the time of sale based upon historical
claims experience. Warranty expense is included in selling expense in the consolidated financial statements.
Engineering and Product Development
Engineering and product development costs, which consist primarily of the salary and related benefits costs of our technical
staff, as well as the cost of materials used in product development, are expensed as incurred.
Foreign Currency
For our foreign subsidiaries whose functional currencies are not the U.S. dollar, assets and liabilities are translated using the
exchange rate in effect at the balance sheet date. The results of operations are translated using an average exchange rate for the
period. The effects of rate fluctuations in translating assets and liabilities of these international operations into U.S. dollars are
included in accumulated other comprehensive earnings in stockholders' equity. Transaction gains or losses are included in net
earnings. For the years ended December 31, 2017 and 2016, foreign currency transaction gains (losses) were $146 and $(16),
respectively.
Income Taxes
The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are
recognized for operating loss and tax credit carryforwards and for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in
tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is
recorded to reduce the carrying amounts of deferred tax assets if it is more likely than not that such assets will not be realized.
On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the “Tax Act”). This
legislation makes significant changes in the U.S. tax laws including reducing the corporate tax rate to 21% starting in 2018 and
creating a territorial tax system with a one-time mandatory transition tax payable on previously unremitted earnings of foreign
subsidiaries, among other things.
F - 10
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
In December 2017, the Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”),
which provides guidance on accounting for enactment effects of the Tax Act. SAB 118 provides a measurement period of up
to one year from the Tax Act’s enactment date for companies to complete their accounting. In accordance with SAB 118, to
the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete, but it is able to determine a
reasonable estimate, it must record a provisional estimate in the financial statements. If a company cannot determine a
provisional estimate to be included in its financial statements, it should continue to account for the provisions of the tax laws
that were in effect immediately before enactment of the Tax Act. As of December 31, 2017, we have reported provisional
amounts for the income tax effects of the Tax Act to the extent a reasonable estimate could be made, and will continue to
refine our estimates throughout the measurement period or until the accounting is complete. See Note 11 for additional
information regarding income taxes.
Net Earnings Per Common Share
Net earnings per common share - basic is computed by dividing net earnings by the weighted average number of common
shares outstanding during each period. Net earnings per common share - diluted is computed by dividing net earnings by the
weighted average number of common shares and common share equivalents outstanding during each period. Common share
equivalents represent unvested shares of restricted stock and stock options and are calculated using the treasury stock method.
Common share equivalents are excluded from the calculation if their effect is anti-dilutive.
The table below sets forth, for the periods indicated, a reconciliation of weighted average common shares outstanding - basic
to weighted average common shares and common share equivalents outstanding - diluted and the average number of
potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their effect was
anti-dilutive:
Weighted average common shares outstanding – basic ................................................. 10,284,572 10,313,747
Potentially dilutive securities:
Years Ended December 31,
2017
2016
Unvested shares of restricted stock and employee stock options ............................
19,173
Weighted average common shares outstanding – diluted .............................................. 10,339,313 10,332,920
18,658
Average number of potentially dilutive securities excluded from calculation ..............
54,741
77,047
Effect of Recently Adopted Amendments to Authoritative Accounting Guidance
In March 2016, the Financial Accounting Standards Board (the "FASB") issued amendments to the current guidance on
accounting for stock-based compensation issued to employees which is contained in ASC Topic 718 (Compensation - Stock
Compensation). The amendments simplify several aspects of the accounting for share-based payment transactions, including
the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash
flows. The amendments were effective for us as of January 1, 2017. The implementation of these amendments did not have a
material impact on our consolidated financial statements.
In July 2015, the FASB issued amendments to update the current guidance on the subsequent measurement of inventory,
which is presented in ASC Topic 330 (Inventory). The purpose of the amendments is to simplify the subsequent measurement
of inventory and reduce the number of potential outcomes. It applies to all inventory other than inventory measured using last-
in, first-out or the retail inventory method. Current guidance requires an entity to measure inventory at the lower of cost or
market. Market could be replacement cost, net realizable value, or net realizable value less a normal profit margin. The
updated guidance amends this to require that an entity measure inventory within the scope of the updated guidance at the
lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less
reasonably predictable costs of completion, disposal, and transportation. The amendments were effective for us as of January
1, 2017. The implementation of these amendments did not have a material impact on our consolidated financial statements.
F - 11
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Effect of Recently Issued Amendments to Authoritative Accounting Guidance
In May 2017, the FASB issued amendments to the guidance on accounting for a change to the terms or conditions
(modification) of a share-based payment award. The amendments provide that an entity should account for the effects of a
modification unless the fair value and vesting conditions of the modified award and the classification of the modified award
(equity or liability instrument) are the same as the original award immediately before the modification. The amendments are
effective for us as of January 1, 2018. Early adoption is permitted. The amendments are to be applied prospectively to an
award modified on or after the adoption date. We do not expect the implementation of these amendments to have a material
impact on our consolidated financial statements.
In January 2017, the FASB issued amendments to the guidance on accounting for goodwill impairment. The amendments
simplify the accounting for goodwill impairment by removing Step II of the goodwill impairment test, which requires a
hypothetical purchase price allocation. Under the amendments, a goodwill impairment will now be the amount by which a
reporting unit's carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The amendments will be
applied prospectively and are effective for us as of January 1, 2020, with early application permitted beginning January 1,
2017. We do not expect the implementation of these amendments to have a material impact on our consolidated financial
statements.
In January 2017, the FASB issued amendments to clarify the current guidance on the definition of a business. The objective of
the amendments is to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals)
of assets or businesses. The amendments are effective for us as of January 1, 2018, with early application permitted. We do not
expect the implementation of these amendments to have a material impact on our consolidated financial statements.
In November 2016, the FASB issued amendments to the guidance on presentation of restricted cash within the statement of
cash flows. The amendments require that restricted cash be included within cash and cash equivalents on the statement of cash
flows. The amendments are effective for us as of January 1, 2018, and are to be applied retrospectively. Early application is
permitted. We do not expect the implementation of these amendments to have a material impact on our consolidated financial
statements.
In February 2016, the FASB issued amendments to the current guidance on accounting for lease transactions, which is
presented in ASC Topic 842 (Leases). Subsequent to February 2016, the FASB has issued additional clarifying guidance on
certain aspects of this new guidance. The intent of the updated guidance is to increase transparency and comparability among
organizations by requiring lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created
by leases and to disclose key information about leasing arrangements. Under the new guidance, a lessee will be required to
record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will
be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income
statement. The amendments are effective for us as of January 1, 2019. A modified retrospective transition approach is required
for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period
presented in the financial statements, with certain practical expedients available. During the fourth quarter of 2017, we
performed a preliminary assessment of the impact that the implementation of this guidance will have on our consolidated
financial statements. Our assessment is ongoing. We currently expect that the implementation of this new guidance will have a
significant impact on our consolidated balance sheet as a result of recording right-of-use assets and lease liabilities for all of
our multi-year leases. Under current guidance, none of these leases has any related asset or liability recorded on our balance
sheet. We do not currently expect that the implementation of this new guidance will have a significant impact on our pattern of
expense recognition for any of our multi-year leases. However, we are still in the process of completing our assessment and
our conclusions about the impact that this new guidance will have on our consolidated financial statements may change as we
complete our assessment over the next several quarters.
In May 2014, the FASB issued new guidance on the recognition of revenue from contracts with customers. Subsequent to May
2014, the FASB has issued additional clarifying guidance on certain aspects of this new guidance. This new guidance is
presented in ASC Topic 606 (Revenue from Contracts with Customers) and will replace most existing revenue recognition
guidance in U.S. GAAP when it becomes effective. Companies can use either the retrospective or cumulative effect transition
method. In August 2015, the FASB deferred the effective date of this new guidance for one additional year. As a result, this
new guidance is effective for us as of January 1, 2018. We will implement this new guidance on January 1, 2018 with a
F - 12
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
cumulative adjustment to retained earnings as opposed to retrospectively adjusting prior periods. During the fourth quarter of
2017, we completed our review of all our revenue streams to identify any differences in timing, measurement or presentation
of revenue recognition. This review included the types of revenue arrangements currently in place including a review of
individual customer contracts related to each of our major revenue streams. Based on the results of our assessment, we have
concluded that the implementation of this new guidance will not have a significant impact on the timing or amount of revenue
we recognize in any given period in comparison to the amount recognized under current guidance. We have also determined
that we will not have a cumulative adjustment to retained earnings to record as of the implementation date. In addition, based
on our assessment, we determined that we did not need to implement any major changes to existing accounting systems or
internal controls.
(3) ACQUISITION
On May 24, 2017, we completed our acquisition of Ambrell, a manufacturer of precision induction heating systems. Ambrell's
systems are used to conduct fast, efficient, repeatable non-contact heating of metals or other electrically conductive materials,
in order to transform raw materials into finished parts. The Ambrell acquisition complements our current thermal technologies
and broadens our diverse customer base, allowing expansion within many non-semiconductor related markets, such as
consumer product packaging, fiber-optics, automotive and other markets.
The purchase price for Ambrell was $22,000 in cash paid at closing, subject to a customary post-closing working capital
adjustment. Additional consideration in the form of earnouts may be paid based upon a multiple of adjusted EBITDA for 2017
and 2018, as further discussed below. The acquisition was completed by acquiring all of the outstanding capital stock of
Ambrell. Total acquisition costs incurred to complete this transaction were $935. Acquisition costs were expensed as incurred
and included in general and administrative expense.
The acquisition of Ambrell has been accounted for as a business combination using purchase accounting, and, accordingly, the
results of Ambrell have been included in our consolidated results of operations from the date of acquisition. The allocation of
the Ambrell purchase price was based on fair values as of May 24, 2017. The determination of fair value reflects the assistance
of third-party valuation specialists, as well as our own estimates and assumptions.
The excess of the purchase price over the identifiable intangible and net tangible assets was allocated to goodwill and is not
deductible for tax purposes. Goodwill is attributed to synergies that are expected to result from the operations of the combined
businesses.
The total purchase price of $26,733 was comprised of:
Cash paid to acquire the capital stock of Ambrell ................................................ $ 22,610
Estimated fair value of contingent consideration .................................................
4,123
Total purchase price ............................................................................................. $ 26,733
As noted above, the consideration paid for the acquisition of Ambrell includes contingent consideration in the form of earnouts
based on the future adjusted EBITDA of Ambrell. Adjusted EBITDA is earnings (or loss) from operations before interest
expense, benefit or provision for income taxes, depreciation and amortization, and excludes other non-recurring income and
expense items as defined in the stock purchase agreement for Ambrell. The first earnout, to be paid after calendar year 2017 is
completed, is an amount equal to 8x Ambrell's adjusted EBITDA for 2017 minus the $22,000 paid at closing as well as the
$175 management bonus for 2017 accrued at the closing. At December 31, 2017, we have accrued $5,355 as additional
acquisition consideration payable on our balance sheet representing the amount of the first earnout. The second earnout, if any,
to be paid after calendar year 2018 is completed, will be an amount equal to 8x Ambrell's adjusted EBITDA for 2018 minus
the sum of the $22,000 paid at closing and the earnout paid with respect to 2017. The 2017 and 2018 earnouts, in the
aggregate, are capped at $18,000. To estimate the fair value of the contingent consideration at the acquisition date, an option
based income approach using a Monte Carlo simulation model was utilized due to the non-linear payout structure. This
resulted in an estimated fair value of $4,123, which was recorded as a contingent consideration liability as of the acquisition
date.
F - 13
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(3) ACQUISITION (Continued)
The total purchase price of $26,733 has been allocated as follows:
Goodwill ............................................................................................................... $ 12,032
Identifiable intangible assets ................................................................................
16,300
Tangible assets acquired and liabilities assumed:
Cash ................................................................................................................
Trade accounts receivable ...............................................................................
Inventories ......................................................................................................
Other current assets .........................................................................................
Property and equipment ..................................................................................
Accounts payable ............................................................................................
Accrued expenses............................................................................................
Customer advances .........................................................................................
Deferred tax liability .......................................................................................
648
3,621
1,917
200
614
(1,420 )
(1,280 )
(554 )
(5,345 )
Total purchase price ............................................................................................. $ 26,733
We estimated the fair value of identifiable intangible assets acquired using a combination of the income, cost and market
approaches. Identifiable intangible assets acquired include customer relationships, customer backlog, technology and
trademarks. We generally amortize our finite-lived intangible assets over their estimated useful lives on a straight-line basis,
unless an alternate amortization method can be reliably determined. Any such alternate amortization method would be based
on the pattern in which the economic benefits of the intangible asset are expected to be consumed.
The following table summarizes the estimated fair value of Ambrell's identifiable intangible assets and their estimated useful
lives as of the acquisition date:
Fair
Value
Weighted
Average
Estimated
Useful Life
(in years)
Finite-lived intangible assets:
Customer relationships ........................................................................... $
Technology ............................................................................................
Customer backlog ..................................................................................
Total finite-lived intangible assets ...............................................................
Indefinite-lived intangible assets:
9,000
600
500
10,100
9.0
9.0
0.3
8.6
Trademarks ............................................................................................
Total intangible assets ................................................................................. $
6,200
16,300
For the period from May 24, 2017 to December 31, 2017, Ambrell contributed $13,562 of net revenues and had a net loss of
$6,238, which includes the impact of a $6,976 increase in the amount of our contingent consideration liability since the date of
acquisition.
The following unaudited pro forma information gives effect to the acquisition of Ambrell as if the acquisition occurred on
January 1, 2016. These proforma summaries do not reflect any operating efficiencies or costs savings that may be achieved by
the combined businesses. These proforma summaries are presented for informational purposes only and are not necessarily
indicative of what the actual results of operations would have been had the acquisition taken place as of that date, nor are they
indicative of future consolidated results of operations:
Net revenues .............................................................................................. $ 74,421 $ 60,410
1,796
Net earnings............................................................................................... $ 1,637 $
0.17
0.16 $
Diluted earnings per share ......................................................................... $
Year Ended
December 31,
2016
2017
F - 14
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(3) ACQUISITION (Continued)
The pro forma results shown above do not reflect the impact on general and administrative expense of investment advisory
costs, legal costs and other costs of $935 incurred by us as a direct result of the transaction. The pro forma results shown above
include a $6,976 increase in the amount of our contingent consideration liability which we recorded during the second half of
2017.
(4) FAIR VALUE MEASUREMENTS
ASC Topic 820 (Fair Value Measurement) establishes a fair value hierarchy for instruments measured at fair value that
distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs).
Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained
from sources independent of us. Unobservable inputs are inputs that reflect our assumptions about the inputs that market
participants would use in pricing the asset or liability, and are developed based on the best information available in the
circumstances.
ASC 820 identifies fair value as the exchange price, or exit price, representing the amount that would be received to sell an
asset or paid to transfer a liability in an orderly transaction between market participants. As a basis for considering market
participant assumptions in fair value measurements, ASC 820 establishes a three-tier fair value hierarchy that distinguishes
among the following:
Level 1 Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the
ability to access.
Level 2 Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or
similar assets or liabilities in markets that are not active and models for which all significant inputs are
observable, either directly or indirectly.
Level 3 Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the
determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by us in determining fair
value is greatest for instruments categorized in Level 3. A financial instrument's level within the fair value hierarchy is based
on the lowest level of any input that is significant to the fair value measurement.
Recurring Fair Value Measurements
The contingent consideration liability on our balance sheet is measured at fair value on a recurring basis using Level 3 inputs.
Our contingent consideration liability is a result of our acquisition of Ambrell on May 24, 2017, and it represents the estimated
fair value of the additional cash consideration payable that is contingent upon the achievement of certain financial results by
Ambrell in 2018, as discussed more fully in Note 3. We use an option based income approach using a Monte Carlo simulation
model to estimate the fair value of the contingent consideration as of the end of each quarter which involves generating
various scenarios for projected adjusted EBITDA over a specified time period, calculating the associated contingent
consideration payments and discounting the average payments to present value. Significant variation in the amount of the
estimated fair value of contingent consideration from period to period is possible as the fair value is affected by our then
current estimation of future events including future net revenues and other items that affect future projected adjusted EBITDA.
During the second half of 2017, we recorded a $6,976 increase in the fair value of our contingent consideration liability. These
increases primarily reflect higher actual adjusted EBITDA for the year ended December 31, 2017 as a result of significantly
higher than expected levels of net revenues and EBITDA in the fourth quarter of 2017 and an increase in the projected
adjusted EBITDA for the year ended December 31, 2018, also as a result of current forecasts for net revenues and EBITDA in
2018 which exceed the amounts projected as of the acquisition date.
The following fair value hierarchy table presents information about liabilities measured at fair value on a recurring basis:
As of December 31, 2017
Contingent consideration liability .......................................... $ 5,744
$
- $
- $ 5,744
Amounts at Fair Value Measurement Using
Fair Value Level 1 Level 2 Level 3
F - 15
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(4) FAIR VALUE MEASUREMENTS (Continued)
Changes in the fair value of our Level 3 contingent consideration liability for the year ended December 31, 2017 were as
follows:
Balance at beginning of period ............................................................................................................. $
Contingent consideration liability established in connection with the acquisition of Ambrell ............
Fair value adjustment ...........................................................................................................................
Transfer of contingent consideration liability to 2017 earnout payable ...............................................
-
4,123
6,976
(5,355 )
Balance at end of period ....................................................................................................................... $
5,744
(5) GOODWILL AND INTANGIBLE ASSETS
Year Ended
December 31,
2017
Goodwill and intangible assets on our balance sheets are the result of our acquisitions of Sigma Systems Corp. ("Sigma")
in October 2008, Thermonics, Inc. ("Thermonics") in January 2012 and Ambrell in May 2017. All of our goodwill and
intangible assets are allocated to our Thermal segment.
Goodwill
Changes in the amount of the carrying value of goodwill for the year ended December 31, 2017 are as follows:
Balance - January 1, 2017 ...................................................... $ 1,656 $
Acquisition of Ambrell ...........................................................
Balance - December 31, 2017 ................................................ $ 1,656 $
-
50
-
50
1,706
- $
$
12,032 12,032
$ 12,032 $ 13,738
Sigma Thermonics Ambrell Total
Intangible Assets
Changes in the amount of the carrying value of finite-lived intangible assets for the year ended December 31, 2017 are as
follows:
Balance - January 1, 2017 .................................................................................. $
365
Acquisition of Ambrell ....................................................................................... 10,100
(1,161 )
Amortization .......................................................................................................
9,304
Balance - December 31, 2017 ............................................................................ $
The following tables provide further detail about our intangible assets as of December 31, 2017 and 2016:
December 31, 2017
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Finite-lived intangible assets:
Customer relationships ..................................................................... $ 10,480
600
Technology .......................................................................................
590
Patents ...............................................................................................
270
Software ............................................................................................
140
Trade name .......................................................................................
500
Customer backlog .............................................................................
Total finite-lived intangible assets ........................................................ 12,580
Indefinite-lived intangible assets:
$ 1,828
95
463
250
140
500
3,276
$ 8,652
505
127
20
-
-
9,304
Trademarks .......................................................................................
6,710
Total intangible assets .......................................................................... $ 19,290
-
$ 3,276
6,710
$ 16,014
F - 16
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(5) GOODWILL AND INTANGIBLE ASSETS (Continued)
December 31, 2016
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Finite-lived intangible assets:
Customer relationships ..................................................................... $
Patents ...............................................................................................
Software ............................................................................................
Trade name .......................................................................................
Total finite-lived intangible assets ........................................................
Indefinite-lived intangible assets:
$
$
1,480
590
270
140
2,480
1,328
424
223
140
2,115
Sigma trademark ...............................................................................
Total intangible assets .......................................................................... $
510
2,990
$
-
2,115
$
152
166
47
-
365
510
875
We generally amortize our finite-lived intangible assets over their estimated useful lives on a straight-line basis, unless an
alternate amortization method can be reliably determined. Any such alternate amortization method would be based on the
pattern in which the economic benefits of the intangible asset are expected to be consumed. None of our intangible assets
have any residual value.
Total amortization expense for our finite-lived intangible assets was $1,161 and $229, respectively, for the years ended
December 31, 2017 and 2016. The following table sets forth the estimated annual amortization expense for each of the next
five years:
2018 ...................................................................................................... $ 1,102
2019 ...................................................................................................... $ 1,257
2020 ...................................................................................................... $ 1,234
2021 ...................................................................................................... $ 1,227
2022 ...................................................................................................... $ 1,167
Impairment of Goodwill and Indefinite Life Intangible Assets
During December 2017 and 2016, we assessed our goodwill and indefinite life intangible asset for impairment in accordance
with the requirements of ASC Topic 350 (Intangibles - Goodwill and Other). Our goodwill impairment assessment is based
upon a combination of the income approach, which estimates the fair value of our reporting units based upon a discounted
cash flow approach, and the market approach which estimates the fair value of our reporting units based upon comparable
market multiples. This fair value is then reconciled to our market capitalization at year end with an appropriate control
premium. The discount rates used in 2017 and 2016 for the discounted cash flows were 14.5% and 18.5%, respectively. The
selection of these rates was based upon our analysis of market based estimates of capital costs and discount rates. The peer
companies used in the market approach operate in our market segment. The determination of the fair value of our reporting
units requires management to make significant estimates and assumptions including the selection of appropriate peer group
companies, control premiums, discount rate, terminal growth rates, forecasts of revenue and expense growth rates, income tax
rates, changes in working capital, depreciation, amortization and capital expenditures. Changes in assumptions concerning
future financial results or other underlying assumptions could have a significant impact on either the fair value of the reporting
unit or the amount of the goodwill impairment charge.
During the goodwill impairment assessment in both 2017 and 2016, we performed a Step I test to identify potential
impairment, in which the fair value of the Thermal reporting unit was compared with its book value. This assessment indicated
no impairment existed as the fair value of this reporting unit was determined to exceed its carrying value.
During the indefinite life intangible asset impairment assessment in both 2017 and 2016, we compared the fair value of our
intangible asset with its carrying amount. This assessment indicated no impairment existed as the fair value of the intangible
assets exceeded their carrying values in both 2017 and 2016.
F - 17
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(5) GOODWILL AND INTANGIBLE ASSETS (Continued)
Impairment of Long-Lived Assets and Finite-lived Intangible Assets
As previously noted, our long-lived assets consist of our finite-lived intangible assets and property and equipment. During
2016, the operations of what was then reported as our Mechanical Products segment were substantially restructured. However,
as this segment still experienced an operating loss for 2016, we performed an assessment of the long-lived assets of this
segment for impairment during December 2016. Our assessment indicated that the property and equipment that was allocated
to this segment was not impaired. During 2016, we did not review the long lived assets of our remaining operations for
impairment as there were no events or changes in business circumstances that would indicate an impairment might exist.
During 2017, we did not review any of our long lived assets for impairment as there were no events or changes in business
circumstances that would indicate an impairment might exist.
(6) MAJOR CUSTOMERS
During the years ended December 31, 2017 and 2016, Hakuto Co. Ltd., one of our distributors, accounted for 11% and 13% of
our consolidated net revenues, respectively. These revenues were generated by our Thermal segment. During the years ended
December 31, 2017 and 2016, Texas Instruments Incorporated accounted for 11% and 10% of our consolidated net revenues,
respectively. While both of our operating segments sold products to this customer, these revenues were primarily generated by
our EMS segment. During the years ended December 31, 2017 and 2016, no other customer accounted for 10% or more of our
consolidated net revenues.
(7) INVENTORIES
Inventories held at December 31 were comprised of the following:
Raw materials ....................................................................................... $ 3,424 $
791
Work in process ....................................................................................
64
Inventory consigned to others ..............................................................
Finished goods......................................................................................
687
Total inventories ................................................................................... $ 4,966 $
2,695
728
81
172
3,676
2017
2016
(8) OTHER CURRENT LIABILITIES
Other current liabilities at December 31 were comprised of the following:
Accrued warranty ................................................................................. $
Other .....................................................................................................
Total other current liabilities ................................................................ $
233 $
166
399 $
125
48
173
2017
2016
(9) DEBT
Letters of Credit
We have issued letters of credit as the security deposits for certain of our domestic leases. These letters of credit are secured by
pledged certificates of deposit which are classified as Restricted Certificates of Deposit on our balance sheets. The terms of
our leases require us to renew these letters of credit at least 30 days prior to their expiration dates for successive terms of not
less than one year until lease expiration. Our outstanding letters of credit at December 31, 2017 and 2016 consisted of the
following:
F - 18
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(9) DEBT (Continued)
Facility
Mt. Laurel, NJ
Mansfield, MA
Original L/C
Issue Date
L/C
Expiration
Date
Lease
Expiration
Date
Letters of Credit
Amount Outstanding
Dec. 31
2017
Dec. 31
2016
3/29/2010
10/27/2010
3/31/2018 4/30/2021 $
11/08/2018 8/31/2021
$
125 $
50
175 $
125
50
175
(10) COMMITMENTS AND CONTINGENCIES
Operating Lease Commitments
We lease our offices, warehouse facilities and certain equipment under non-cancellable operating leases which expire at
various dates through 2029. Total rental expense for the years ended December 31, 2017 and 2016 was $1,600 and $1,241,
respectively. Certain of our operating leases contain predetermined fixed escalations of minimum rentals and rent holidays
during the original lease terms. Rent holidays are periods during which we have control of the leased facility but are not
obligated to pay rent. For these leases, we recognize the related rental expense on a straight-line basis over the life of the lease,
which includes any rent holiday, and record the difference between the amounts charged to operations and amounts paid as
Accrued Rent on our balance sheet. In addition to the monthly rental payments due, most of our leases for our offices and
warehouse facilities require us to pay our portion of the common area maintenance, property taxes and insurance charges
incurred by the landlord for the facilities which we occupy. These amounts are not included in the minimum rental
commitments disclosed below as they are based on actual charges incurred in the periods to which they apply.
The aggregate minimum rental commitments under the non-cancellable operating leases in effect at December 31, 2017 are as
follows:
2018 ................................................................................................................. $ 1,778
2019 ................................................................................................................. 1,638
2020 ................................................................................................................. 1,592
844
2021 .................................................................................................................
291
2022 .................................................................................................................
Thereafter ........................................................................................................ 1,739
Total ................................................................................................................ $ 7,882
(11) INCOME TAXES
We are subject to Federal and certain state income taxes. In addition, we are taxed in certain foreign countries.
As previously discussed in Note 2, on December 22, 2017 the President of the United States signed into law the Tax Act. The
two principal elements of the Tax Act impacting our 2017 consolidated statement of operations and our balance sheet as of
December 31, 2017 are the reduction in the corporate tax rate from 35% to 21% and the one-time transition tax that is imposed
on the previously unremitted earnings of our foreign subsidiaries. As a result of the legislative changes enacted, we were
required to revalue our deferred tax assets and liabilities to the new rate of 21% as of December 31, 2017, which resulted in
our recording a current period tax benefit of $1,743 in our 2017 consolidated statement of operations and a corresponding
reduction in the amount of the net deferred tax liability. Due to the complexities involved in determining the previously
unremitted earnings of our foreign subsidiaries, we are still in the process of obtaining, preparing and analyzing the required
information. We have recorded a provisional amount for the transition tax payable on those unremitted earnings. The
provisional amount recorded, net of related foreign tax credits, is a tax of approximately $476. The rate of tax paid is 14% of
the foreign earnings.
F - 19
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(11) INCOME TAXES (Continued)
Earnings before income taxes was as follows:
Years Ended
December 31,
2016
2017
Domestic .............................................................................................. $ 2,580 $
1,258
Foreign .................................................................................................
Total ..................................................................................................... $ 3,838 $
3,345
862
4,207
Income tax expense (benefit) was as follows:
Years Ended
December 31,
2016
2017
Current
Domestic – Federal ........................................................................... $ 4,106 $
175
Domestic – state ................................................................................
Foreign ..............................................................................................
212
Total .................................................................................................. $ 4,493 $
Deferred
Domestic – Federal ........................................................................... $ (1,886 ) $
244
Domestic – state ................................................................................
12
Foreign ..............................................................................................
(1,630 )
Total ..................................................................................................
Income tax expense .............................................................................. $ 2,863 $
1,295
74
45
1,414
(39 )
10
164
135
1,549
Deferred income taxes reflect the net tax effect of net operating loss and tax credit carryforwards as well as temporary
differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for
income tax purposes. The following is a summary of the significant components of our deferred tax assets and liabilities as of
December 31, 2017 and 2016:
December 31,
2016
2017
Deferred tax assets:
Net operating loss (state and foreign) ............................................... $
Tax credit carryforwards ...................................................................
Inventories ........................................................................................
Accrued vacation pay and stock-based compensation ......................
Depreciation of property and equipment ..........................................
Allowance for doubtful accounts ......................................................
Accrued warranty ..............................................................................
Acquisition costs ...............................................................................
Intangibles ........................................................................................
Other .................................................................................................
Total ..................................................................................................
Valuation allowance .............................................................................
Deferred tax assets ...............................................................................
Deferred tax liabilities:
444 $
206
185
156
97
47
20
15
-
15
1,185
(370 )
815
71
-
182
161
580
55
9
28
311
7
1,404
-
1,404
(3,421 )
Net intangible assets .........................................................................
-
Unremitted earnings of foreign subsidiaries .....................................
Deferred tax liabilities ..........................................................................
(3,421 )
Net deferred tax assets (liabilities) ....................................................... $ (2,606 ) $
(212 )
(82 )
(294 )
1,110
F - 20
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(11) INCOME TAXES (Continued)
The net change in the valuation allowance for the years ended December 31, 2017 and 2016 was an increase of $370 and a
decrease of $15, respectively. In assessing the ability to realize the deferred tax assets, we consider whether it is more likely
than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets
is dependent upon the generation of future taxable income during periods in which those temporary differences become
deductible. We consider the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning
strategies in making this assessment. In order to fully realize the total deferred tax assets, we will need to generate future
taxable income prior to the expiration of net operating loss and tax credit carryforwards which expire in various years
through 2037.
An analysis of the effective tax rate for the years ended December 31, 2017 and 2016 and a reconciliation from the expected
statutory rate of 35% (for 2017) and 34% (for 2016) is as follows:
Years Ended
December 31,
2016
2017
Expected income tax provision at U.S. statutory rate ........................... $ 1,343 $
Increase (decrease) in tax from:
Federal tax rate changes ....................................................................
Current year tax credits (foreign and research) .................................
Domestic production activities deduction .........................................
Foreign income tax rate differences ..................................................
Restricted stock .................................................................................
Nondeductible expenses ...................................................................
Domestic tax expense, net of Federal benefit ...................................
Federal transition tax payable ...........................................................
Deemed dividend from foreign subsidiaries .....................................
Acquisition costs ...............................................................................
NOL carryforwards utilized ..............................................................
Changes in valuation allowance........................................................
Other .................................................................................................
(1,843 )
(379 )
(290 )
(229 )
(59 )
2,463
791
476
423
142
36
17
(28 )
Income tax expense .............................................................................. $ 2,863 $
1,430
-
(140 )
(112 )
(258 )
-
14
55
-
396
-
180
(15 )
(1 )
1,549
In accounting for income taxes, we follow the guidance in ASC Topic 740 (Income Taxes) regarding the recognition and
measurement of uncertain tax positions in our financial statements. Recognition involves a determination of whether it is more
likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be
examined by the appropriate taxing authority having full knowledge of all relevant information. Our policy is to record interest
and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of
December 31, 2017 and 2016, we did not have an accrual for uncertain tax positions.
We file U.S. income tax returns and multiple state and foreign income tax returns. With few exceptions, the U.S. and state
income tax returns filed for the tax years ending on December 31, 2015 and thereafter are subject to examination by the
relevant taxing authorities. During the first quarter of 2017, the U.S. taxing authority completed an examination of our federal
income tax return for the year ended December 31, 2014 and there were no changes to the tax return as originally filed.
(12) LEGAL PROCEEDINGS
From time to time we may be a party to legal proceedings occurring in the ordinary course of business. We are not currently
involved in any legal proceedings the resolution of which we believe could have a material effect on our business, financial
position, results of operations or long-term liquidity.
F - 21
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(13) STOCK-BASED COMPENSATION PLAN
As of December 31, 2017, we have unvested restricted stock awards and stock options outstanding which were granted under
the inTEST Corporation 2007 Stock Plan (the "2007 Stock Plan") and the inTEST Corporation 2014 Stock Plan (the "2014
Stock Plan"). The 2007 Stock Plan was approved at our annual meeting of stockholders held on June 13, 2007 and permits the
granting of stock options or restricted stock for up to 500,000 shares of our common stock to officers, other key employees
and consultants. The 2014 Stock Plan was approved at our annual meeting of stockholders held on June 25, 2014 and permits
the granting of stock options, restricted stock, stock appreciation rights or restricted stock units for up to 500,000 shares of our
common stock to directors, officers, other key employees and consultants. As of December 31, 2017, there were 345,200
aggregate shares available to grant under these plans.
Our unvested restricted stock awards and stock options are accounted for based on their grant date fair value. As of December
31, 2017, total compensation expense to be recognized in future periods was $455. The weighted average period over which
this expense is expected to be recognized is 2.9 years.
The following table summarizes the compensation expense we recorded during 2017 and 2016, related to unvested shares of
restricted stock and stock options.
Cost of revenues ................................................................................... $
Selling expense .....................................................................................
Engineering and product development expense ...................................
General and administrative expense .....................................................
$
6 $
-
5
333
344 $
10
6
11
242
269
Years Ended
December 31,
2017
2016
There was no compensation expense capitalized in 2017 or 2016.
Stock Options
We record compensation expense for stock options based on the fair market value of the options as of the grant date. No
option may be granted with an exercise period in excess of ten years from the date of grant. Generally, stock options will be
granted with an exercise price equal to the fair market value of our stock on the date of grant and will vest over four years.
The fair value for stock options granted during 2017 and 2016 was estimated at the date of grant using the Black-Scholes
option pricing model with the following weighted average assumptions:
Risk-free interest rate ...............................................................................
Dividend yield ..........................................................................................
Expected common stock market price volatility factor ............................
Weighted average expected life of stock options (years) .........................
2.14%
0.00%
.39
6
1.30 %
0.00 %
.40
4
2017
2016
The per share weighted average fair value of stock options issued during 2017 and 2016 was $2.64 and $1.43, respectively.
F - 22
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(13) STOCK-BASED COMPENSATION PLAN (Continued)
The following table summarizes the activity related to stock options for the two years ended December 31, 2017:
Options outstanding, January 1, 2016 ..................................................
Granted .............................................................................................
Exercised ..........................................................................................
Canceled ...........................................................................................
Options outstanding, December 31, 2016 (none exercisable) ..............
Granted .............................................................................................
Exercised ..........................................................................................
Canceled ...........................................................................................
Options outstanding, December 31, 2017 (4,950 exercisable) .............
Number
of Shares
-
19,800
-
-
19,800
96,000
-
(39,400)
76,400
Weighted
Average
Exercise Price
$
-
4.37
-
-
4.37
6.35
-
6.08
5.98
Restricted Stock Awards
We record compensation expense for restricted stock awards (unvested shares) based on the quoted market price of our stock
at the grant date and amortize the expense over the vesting period. Restricted stock awards generally vest over four years.
The following table summarizes the activity related to unvested shares for the two years ended December 31, 2017:
Unvested shares outstanding, January 1, 2016 .....................................
Granted .............................................................................................
Vested ...............................................................................................
Forfeited ............................................................................................
Unvested shares outstanding, December 31, 2016 ...............................
Granted .............................................................................................
Vested ...............................................................................................
Forfeited ............................................................................................
Unvested shares outstanding, December 31, 2017 ...............................
Weighted
Average
Grant Date
Fair Value
3.64
4.27
3.94
-
4.04
6.54
4.65
5.59
5.29
Number
of Shares
63,750
86,400
(53,125 )
-
97,025
66,000
(69,100 )
(18,700 )
75,225
The total fair value of the shares that vested during the years ended December 31, 2017 and 2016 was $493 and $208,
respectively, as of the vesting dates of these shares.
(14) STOCK REPURCHASE PLAN
On October 27, 2015, our Board of Directors authorized the repurchase of up to $5,000 of our common stock from time to
time on the open market, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, or in privately
negotiated transactions (the "2015 Repurchase Plan"). Repurchases may also be made under trading plans entered into with
RW Baird & Co. (each a "10b5-1 Plan"), which permit shares to be repurchased when we might otherwise be precluded from
doing so under insider trading laws. The 2015 Repurchase Plan does not obligate us to repurchase any particular amount of
common stock and may be suspended or discontinued at any time without prior notice. The 2015 Repurchase Plan is funded
using our operating cash flow or available cash. The timing, price and amount of any shares repurchased under the 2015
Repurchase Plan is determined by our management, based on our evaluation of market conditions and other factors. To date,
all purchases have been made in accordance with 10b5-1 Plans which provided for purchases to be made so long as the price
did not exceed a maximum price. Recently, the price of our shares has exceeded the cap. Management is considering new
parameters for future purchases and may enter into a new 10b5-1 Plan at some point under those new parameters. As of
December 31, 2017, all of the Company’s 10b5-1 Plans had expired.
F - 23
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(14) STOCK REPURCHASE PLAN (Continued)
During 2017 and 2016, we repurchased 13,883 and 241,805 shares under the 2015 Repurchase Plan, respectively. The total
cost to repurchase these shares, including fees paid to our broker, was $62 and $978, respectively. As of December 31, 2017,
we had repurchased a total of 297,020 shares under the 2015 Repurchase Plan at a cost of $1,195. All of the repurchased
shares were retired.
(15) EMPLOYEE BENEFIT PLANS
We have defined contribution 401(k) plans for our employees who work in the U.S. All permanent employees of inTEST
Corporation, Temptronic Corporation (“Temptronic”) and inTEST Silicon Valley Corporation who are at least 18 years of age
are eligible to participate in the inTEST Corporation Incentive Savings Plan. We match employee contributions dollar for
dollar up to 10% of the employee's annual compensation, with a maximum limit of $5. Employer contributions vest ratably
over four years. Matching contributions are discretionary. For the years ended December 31, 2017 and 2016, we recorded
$338 and $347 of expense for matching contributions, respectively.
All permanent employees of Ambrell are immediately eligible to participate in the Ambrell Corporation Savings & Profit
Sharing Plan (the "Ambrell Plan") upon employment and are eligible for employer matching contributions after completing
one year of service, as defined in the Ambrell Plan. The Ambrell Plan allows eligible employees to make voluntary
contributions up to 100% of compensation, up to the federal government contribution limits. We will make a matching
contribution of 25% of each employee's contributions up to a maximum of 2% of such employee's annual compensation. From
the date of acquisition through December 31, 2017, we made matching contributions of $35.
(16) SEGMENT INFORMATION
As discussed in Note 1, during 2016, we reorganized our business from three product segments (Thermal Products,
Mechanical Products and Electrical Products) into two product segments (Thermal and EMS). Accordingly, effective January
1, 2017, we have two reportable segments, which are also our reporting units. Prior period information has been reclassified to
be comparable to the presentation for 2017.
Thermal includes the operations of Temptronic, Thermonics, Sigma, inTEST Thermal Solutions GmbH (Germany), inTEST
Pte, Limited (Singapore) and Ambrell, which we acquired in May 2017, as discussed in Note 3. Sales of this segment consist
primarily of temperature management systems which we design, manufacture and market under our Temptronic, Thermonics
and Sigma product lines, and precision induction heating systems which are designed, manufactured and marketed by
Ambrell. In addition, this segment provides post-warranty service and support.
EMS includes the operations of our manufacturing facilities in Mt. Laurel, New Jersey and Fremont, California. Sales of this
segment consist primarily of manipulator, docking hardware and tester interface products, which we design, manufacture and
market.
We operate our business worldwide and sell our products both domestically and internationally. Both of our segments sell to
semiconductor manufacturers, third-party test and assembly houses and ATE manufacturers. Thermal also sells into a variety
of markets outside of the ATE market, including the automotive, consumer electronics, consumer product packaging,
defense/aerospace, energy, fiber optics, industrial, telecommunications and other markets.
Years Ended
December 31,
2017
2016
Net revenues from unaffiliated customers:
Thermal ................................................................................................ $ 42,233 $
24,568
EMS......................................................................................................
$ 66,801 $
24,033
16,194
40,227
Depreciation/amortization:
Thermal ................................................................................................ $
EMS......................................................................................................
$
1,628 $
151
1,779 $
440
159
599
F - 24
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(16) SEGMENT INFORMATION (Continued)
Operating income (loss):
Thermal ................................................................................................ $
EMS......................................................................................................
Corporate ..............................................................................................
$
Earnings (loss) before income tax expense (benefit):
Thermal ................................................................................................ $
EMS......................................................................................................
Corporate ..............................................................................................
$
Income tax expense (benefit):
Thermal ................................................................................................ $
EMS......................................................................................................
Corporate ..............................................................................................
$
Net earnings (loss):
Thermal ................................................................................................ $
EMS......................................................................................................
Corporate ..............................................................................................
$
Capital expenditures:
Thermal ................................................................................................ $
EMS......................................................................................................
$
Years Ended
December 31,
2017
2016
(822 ) $
6,830
(2,397 )
3,611 $
(686 ) $
6,869
(2,345 )
3,838 $
1,665 $
1,819
(621 )
2,863 $
(2,351 ) $
5,050
(1,724 )
975 $
659 $
86
745 $
4,210
989
(1,053 )
4,146
4,193
1,021
(1,007 )
4,207
1,544
376
(371 )
1,549
2,649
645
(636 )
2,658
262
77
339
December 31,
2017
2016
Identifiable assets:
Thermal ................................................................................................ $ 50,408 $
12,085
EMS......................................................................................................
$ 62,493 $
19,893
22,951
42,844
The following table provides information about our geographic areas of operation. Net revenues from unaffiliated customers are
based on the location to which the goods are shipped.
Years Ended
December 31,
2017
2016
Net revenues from unaffiliated customers:
U.S. ....................................................................................................... $
Foreign .................................................................................................
$
20,205 $
46,596
66,801 $
13,061
27,166
40,227
Property and equipment:
U.S. ....................................................................................................... $
Foreign .................................................................................................
$
991 $
550
1,541 $
691
253
944
December 31,
2017
2016
F - 25
inTEST CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(17) QUARTERLY CONSOLIDATED FINANCIAL DATA (Unaudited)
The following tables present certain unaudited consolidated quarterly financial information for each of the eight quarters ended
December 31, 2017. In our opinion, this quarterly information has been prepared on the same basis as the consolidated financial
statements and includes all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the
information for the periods presented. The results of operations for any quarter are not necessarily indicative of results for the
full year or for any future period.
Year-over-year quarterly comparisons of our results of operations may not be as meaningful as the sequential quarterly
comparisons set forth below that tend to reflect the cyclical and seasonal activity of the semiconductor and ATE markets.
Quarterly fluctuations in expenses are related directly to sales activity and volume and may also reflect the timing of operating
expenses incurred throughout the year.
Quarters Ended
3/31/17
6/30/17
9/30/17(1) 12/31/17(2)(3) Total
Net revenues ....................................................................... $
Gross margin ......................................................................
Earnings (loss) before income tax expense ........................
Income tax expense ............................................................
Net earnings (loss)..............................................................
14,180 $
7,728
3,172
1,094
2,078
15,888 $
8,421
2,336
891
1,445
17,352 $
8,796
2,841
823
2,018
19,381 $
9,745
(4,511 )
55
(4,566 )
66,801
34,690
3,838
2,863
975
Net earnings (loss)per common share – basic .................... $
0.09
Weighted average common shares outstanding – basic ..... 10,264,565 10,277,155 10,288,325 10,308,243 10,284,572
Net earnings (loss) per common share – diluted ................ $
0.09
Weighted average common shares outstanding – diluted .. 10,295,337 10,334,894 10,351,009 10,308,243 10,339,313
(0.44 ) $
(0.44 ) $
0.20 $
0.20 $
0.20 $
0.19 $
0.14 $
0.14 $
Net revenues ....................................................................... $
Gross margin ......................................................................
Earnings before income tax expense ..................................
Income tax expense ............................................................
Net earnings .......................................................................
8,647 $
4,067
124
43
81
10,485 $
5,329
749
263
486
12/31/16 Total
10,272 $
5,405
1,613
612
1,001
40,227
20,378
4,207
1,549
2,658
10,823 $
5,577
1,721
631
1,090
Quarters Ended
3/31/16
6/30/16
9/30/16
Net earnings per common share – basic ............................. $
0.26
Weighted average common shares outstanding – basic ..... 10,390,002 10,295,836 10,295,447 10,273,702 10,313,747
Net earnings per common share – diluted .......................... $
0.26
Weighted average common shares outstanding – diluted .. 10,404,244 10,310,692 10,318,715 10,297,439 10,332,920
0.01 $
0.01 $
0.10 $
0.10 $
0.11 $
0.11 $
0.05 $
0.05 $
(1)
(2)
(3)
The quarter ended September 30, 2017 includes a $549 reduction in the fair value of contingent consideration, which was
not taxable.
The quarter ended December 31, 2017 includes a $7,525 increase in the fair value of contingent consideration, which was
not deductible for tax purposes.
The quarter ended December 31, 2017 includes adjustments related to tax legislation enacted in December 2017, as
discussed in Note 2 and 11.
F - 26
inTEST CORPORATION
SCHEDULE II -- VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
Balance at
Beginning
of Period
Expense
(Recovery)
Balance at
End of
Period
Deductions
Year Ended December 31, 2017
Allowance for doubtful accounts .............................................................. $
Warranty reserve .......................................................................................
146 $
125
68 $
209
(1) $
(101)
213
233
Year Ended December 31, 2016
Allowance for doubtful accounts .............................................................. $
Warranty reserve .......................................................................................
146 $
94
- $
125
- $
(94)
146
125
F - 27
Reconciliation of Net Earnings (GAAP) and Net Earnings per Share – Diluted (GAAP) to Adjusted
Net Earnings (non-GAAP) and Adjusted Net Earnings per Share – Diluted (non-GAAP):
Appendix A
Net earnings (GAAP)
Acquired intangible amortization
Contingent consideration liability adjustment
Tax adjustments
Years Ended
12/31/2017
12/31/2016
$ 975
$ 2,658
1,161
6,976
(15)
229
-
(28)
Adjusted net earnings (non-GAAP)
$ 9,097
$ 2,859
Diluted weighted average shares outstanding
10,339
10,333
Net earnings per share – diluted:
Net earnings per share (GAAP)
Acquired intangible amortization
Contingent consideration liability adjustment
Tax adjustments
$ 0.09
$ 0.26
0.11
0.68
-
0.02
-
-
Adjusted net earnings per share – diluted (non-GAAP)
$ 0.88
$ 0.28
Company Profile
Corporate
Information
inTEST Corporation (NYSE American:INTT) designs and manufactures engineered solutions for
Automated Test Equipment (ATE) and other electronic test, as well as industrial process applications. Our products
are used by semiconductor manufacturers to perform development, qualifying and final testing of integrated circuits
(ICs) and wafers, and for other electronic test across a range of industries including the automotive, defense/
aerospace, energy, industrial and telecommunications markets. We offer induction heating products for joining
and forming metals in a variety of industrial markets, including automotive, aerospace, machinery, wire & fasteners,
medical, semiconductor, food & beverage, and packaging. Specific products include temperature management
systems, induction heating products, manipulator and docking hardware products, and customized interface
solutions. We have established strong relationships with our customers globally, which we support through a
network of local offices.
Our largest customers include Analog Devices, Inc., Cypress Semiconductor Corporation, Foxconn Optical
Interconnect Technologies, Inc., Hakuto Co. Ltd., NaigaiTEC Corporation, NXP Semiconductors N.V.,
Rosendahl Nextrom GmbH, STMicroelectonics N.V., Teradyne, Inc., and Texas Instruments Incorporated.
We are headquartered in Mt. Laurel, NJ, with manufacturing facilities in NJ, MA, NY and CA. We also have
sales, service and support offices in Singapore, Germany, Netherlands and the U.K., with additional support
personnel in other key industrial manufacturing areas around the world.
BUSINESS SEGMENTS
Thermal Segment
Ambrell
EMS Products Segment
inTEST comprises two
business segments under
five brands – Ambrell,
Temptronic, Sigma
Systems, Thermonics,
and EMS Products –
that collectively focus
on electronic test,
process cooling, and
induction heating.
inTEST Thermal Solutions
(iTS): Thermal systems that
deliver precise temperature
from ultralow to high heat
for thermal conditioning in
electronic and production
test processes, as well as
adding or removing heat to
maintain a thermally stable
manufacturing or test site.
Induction heating
systems that deliver
precise temperature
used in production
processes for conditioning
metals such as annealing,
bonding, brazing, curing,
forging, hardening,
melting, sealing, shrink
fitting, and soldering.
inTEST EMS Products:
Manipulators, docking
systems and custom
electrical interfaces
critical to ATE systems
in the production of
semiconductors.
inTEST-semicon.com
inTESTthermal.com and
Thermonics-chillers.com
Ambrell.com
m
o
c
.
n
g
i
s
e
d
e
r
u
t
a
n
g
i
s
y
e
l
l
e
h
s
.
w
w
w
/
n
g
i
s
e
D
e
r
u
t
a
n
g
S
y
e
i
l
l
e
h
S
:
y
B
n
g
i
s
e
D
t
r
o
p
e
R
l
a
u
n
n
A
Executive Officers
James Pelrin
President and
Chief Executive Officer
Hugh T. Regan, Jr.
Secretary, Treasurer and
Chief Financial Officer
Is Transfer
Agent Copy
OK?
Board of Directors
Robert E. Matthiessen
Chairman, inTEST Corporation
James Pelrin
President and CEO,
inTEST Corporation
Steven J. Abrams, Esq.
Partner, Hogan Lovells US LLP
Joseph W. Dews IV
Partner, AGC Partners
William Kraut
Partner, Newport Board Group LLC
Legal Counsel
Ballard Spahr LLP
1735 Market Street – 51st Floor
Philadelphia, PA 19103-7599
Independent Registered
Public Accounting Firm
RSM US LLP
751 Arbor Way, Suite 200
Blue Bell, PA 19422-2700
Transfer Agent
Computershare Trust Company, N.A.
Attention: Shareholder Services
P.O. Box 505000
Louisville, KY 40233
800-962-4284
Investor Relations
Laura Guerrant-Oiye, Principal
Guerrant Associates
lguerrant@guerrantir.com
808-960-2642
Annual Stockholders’ Meeting
Our 2018 Annual Meeting
of Stockholders will be held
at 11:00 A.M. Eastern
Daylight Time on Wednesday,
June 27, 2018, at our offices,
804 East Gate Drive, Suite 200,
Mt. Laurel, New Jersey 08054.
Availability of Annual Report
on Form 10-K
A copy of our Annual Report
on Form 10-K for the year ended
December 31, 2017 (excluding
exhibits) as filed with the Securities
and Exchange Commission is
available to any stockholder
without charge, upon written
request to Hugh T. Regan, Jr.,
Secretary, inTEST Corporation,
804 East Gate Drive, Suite 200,
Mt. Laurel, NJ 08054, or by
calling (856) 505-8800. Copies
of the exhibits filed therewith will
be provided upon written request
to the Secretary of the Corporation
and payment of a reasonable
fee (which will not exceed our
expense incurred in connection with
providing such copies). In addition,
our Annual Report on Form 10-K
and all exhibits are available at no
charge by accessing the Investor
Relations page of our website, at
http://investor.shareholder.com/
intest/index.cfm, or the SEC’s
website, at www.sec.gov.
InTEST_2017AR_CV.indd 3
4/30/18 1:24 PM
InTEST_2017AR_CV.indd 4
4/30/18 1:24 PM
PRINTER:
PLEASE BUILD
IN SPINE
inTEST Corporation Corporate Headquarters
804 East Gate Drive, Suite 200
Mt. Laurel, NJ 08054 USA
Tel (856) 505-8800 Fax (856) 505-8801
www.intest.com
WE’RE NOT JUST SEMI…
WE’RE NOT JUST SEMI…
WE MAKE THINGS HOT & COLD WHERE IT MATTERS
WE MAKE THINGS HOT & COLD WHERE IT MATTERS
i
n
T
E
S
T
C
o
r
p
o
r
a
t
i
o
n
I
2
0
1
7
A
n
n
u
a
l
R
e
p
o
r
t
InTEST_2017AR_CV.indd 1
InTEST_2017AR_CV.indd 5
4/30/18 1:24 PM
4/30/18 1:24 PM
InTEST_2017AR_CV.indd 2
4/30/18 1:24 PM
001CSN346A
2017 Annual Report